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Abstract 
The ‘wide-awake drunkenness’ hypothesis proposes that consuming alcohol mixed 
with energy drinks (AmED) masks the sedative effects of alcohol, causing 
consumers to misperceive their level of intoxication and consequently engage in 
more risky behaviours (Peacock & Bruno, 2015).  Experimental data suggests a 
trend towards increased risk-taking following AmED consumption driven 
predominantly by the ED, with small magnitude effects (Lubman, 2013; Peacock, 
Bruno, Martin, & Carr, 2013). This study examined AmED effects on risk-taking 
administering standardised ED and alcohol doses, using a naturalistic multi-dose 
design to mimic how AmEDs are consumed in the ‘real-world’. In a placebo-
controlled, within-subjects, double-blind study, participants (N=27) consumed 
alcohol with ED (AmED condition) and soda water (Alcohol-only condition). The 
Automatic Balloon Analogue Risk Task (A-BART) measured risk-taking 
propensity, while the Determination Task (DT) was administered to measure 
frustration tolerance. AmED administration did not significantly increase risk-taking 
propensity as measured by the A-BART, however Reaction Time (RT) on the DT 
was improved following AmED ingestion, indicating improved cognitive function 
relative to alcohol-only, whilst accuracy was not significantly affected. Improved 
cognitive performance may predict underestimation of intoxication as drinkers 
gauge their level of impairment based on cognitive cues (Celio et al., 2014). Future 
research should aim to measure risk-taking behaviour in social drinking 
environments to further improve ecological validity. 
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 The consumption of alcohol mixed with energy drinks (AmED) is a common 
practice among young Australians aged 18-24 (Pennay & Lubman, 2012). Energy 
drinks (ED) generally promote increased alertness and 'energy', thus it is widely 
believed that mixing EDs with alcohol will counteract the sedative effects of alcohol 
(Peacock, Bruno & Martin, 2013).This is theorised to create a state of 'wide-awake 
drunkenness', whereby the consumer believes they are less intoxicated relative to 
consuming the same amount of alcohol without ED. Researchers have speculated 
that this misperception of intoxication may increase the likelihood of engaging in 
risk-taking (Peacock & Bruno, 2015). Current research consists mostly of self-report 
retrospective survey designs (Peacock, Pennay, Droste, Bruno, & Lubman, 2014), 
precluding direct inferences regarding causality. The few experimental studies 
support a trend toward increased risk-taking post ED and AmED administration, 
with small magnitude effects (Lubman, 2013; Peacock et al., 2013). Current 
experimental research is limited in that AmED dosing protocols used in existing 
work do not reflect the quantities and speed at which they are typically consumed 
(Pennay et al., 2015), perhaps explaining the absence of substantive effects. As such, 
there is a need for research that objectively measures risk-taking whilst 
implementing naturalistic dosing. 
Alcohol 
Prevalence and harms. Australian guidelines for minimising acute harm 
when consuming alcohol recommend no more than 4 standard drinks on a single 
occasion (National Health and Medical Research Council, 2009). In 2013, 37% of 
Australians aged 12 years and older exceeded this single occasion risk threshold at 
least once in the past year. People aged 18 to 24 were the age group most likely to 
exceed this threshold (National Drug Strategy Household Survey, 2013). Excessive 
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consumption of alcohol is known to have harmful health, economic and social 
effects. Tangible costs attributable to alcohol totalled 10.8 billion dollars in the 
2004/05 financial year, with labour and health costs constituting the major cost 
components (Collins & Lapsley, 2008). Alcohol intoxication is among the three 
most common causes of fatal car crashes in Australia (Bureau of Transport 
Infrastructure and Regional Economics, 2011) and a review of metropolitan Western 
Australian Emergency department records indicated that the majority (41%) of all 
alcohol and drug related presentations over a four week period were caused by 
alcohol consumption, with injury being the most frequent diagnosis at presentation 
(Hulse, Robertson & Tait, 2002).  
Pharmacokinetics and cognitive effects. Degree of alcohol-related 
impairment is determined by numerous factors including blood alcohol 
concentration and the rate at which the body is able to metabolise alcohol. Ethanol 
(ethyl alcohol) is absorbed through the gastrointestinal tract and is distributed 
through a majority of the water-containing tissues in the body (Naranjo & Bremner, 
1993). Breath alcohol concentration (BrAC) peaks approximately 57 minutes post-
consumption for males and 42 minutes for females (Dubowski, 1985). An average 
70kg person metabolises one standard drink (10g alcohol) per hour (Baraona et al., 
2001). Metabolic rate depends on a variety of situational, physical, biological and 
psychological factors including alcohol concentration, food intake, sex, weight, 
body water and patterns of alcohol consumption (Dubowski, 1985).  
  Ethanol affects the central nervous system (CNS) by acting on receptors in 
the inhibitory γ-aminobutyric acid (GABA) and excitatory N-methyl-D-asparate 
(NMDA glutamate) pathways, producing sedative effects causing a range of 
behavioural and psychomotor impairments (Dougherty, Marsh, Moeller, Chokshi, & 
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Rosen, 2000; Zoethout, Delgado, Ippel, Dahan, & van Gerven, 2011). More 
specifically, behavioural changes in impulsivity caused by ethanol are impacted by 
serotonin function (Dougherty et al., 2007; Eckardt et al., 1998). Acute intoxication 
compromises executive function regulated by the pre-frontal cortex. The 
orbitofrontal area in particular is affected which is implicated in risk assessment and 
inhibition of socially inappropriate behaviours (Berlin, Rolls, & Kischka, 2004; 
Rolls, 2004).  
Acute tolerance. Severity of alcohol-induced behavioural and cognitive 
deficits may change over the BrAC curve, which is a representation of level of 
intoxication over time (Schweizer & Vogel-Sprott, 2008). The curve consists of two 
limbs: ascending, representing the period from ingestion to peak intoxication, and 
descending, representing the post-peak decline (Figure 1). Acute tolerance refers to 
a specific behaviour or function being differentially impaired on the two limbs 
(Schweizer & Vogel-Sprott, 2008). For example, participants in Amlung, Morris, 
and McCarthy's (2014) study were more willing to drive, and judged doing so as less 
dangerous on the descending limb compared to the ascending limb despite having 
the same BrAC. Tolerance is thought to result from a temporary adaptation to the 
physiological effects of alcohol (Peacock, Cash, & Bruno, 2015). 
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Figure 1. The BrAC curve, in which intoxication level rises sharply to a peak before 
declining more slowly over time. 
 
Alcohol and risk-taking. The body of evidence concerning alcohol 
intoxication points unequivocally to greater engagement in risk-taking behaviour 
and consequent experience of harm after consuming alcohol. Indeed, alcohol 
consumption among young people is associated with behaviours such as risky 
driving (Greene, Krcmar, Walters, Rubin, & Hale, 2000) and unsafe sex (Coleman 
& Cater, 2005). For example, drinkers who consume alcohol to the point of 
experiencing impaired judgement or total loss of control have been found to be more 
likely to engage in risky sexual activity (Coleman & Cater, 2005). Although these 
behaviours are regularly referred to as risky, there has been no global consensus as 
to the definition of risk-taking behaviour. Within the current literature the term-risk 
taking is often used interchangeably with sensation-seeking and impulsiveness, yet 
Weafer and Fillmore (2016) argue that they are separate constructs. Impulsivity in 
itself is multifaceted and broadly considered to comprise the tendency to enter 
situations or make quick decisions without consideration of the possible negative or 
Ascending  
Descending 
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aversive outcomes (Zuckerman, 1994b). Sensation-seeking has been referred to as 
the seeking of varied, novel, complex and intense sensations and experiences whilst 
willingly accepting the financial, physical, social and legal consequences of such 
behaviour (Zuckerman, 1994a).  
Risk-taking is seemingly more similar to impulsivity than sensation-seeking, 
defined by Kahneman and Lovallo (1993) as the adoption of an inside view of 
problems, which leads individuals to base decisions on readily available cues rather 
than to consider the consequences of such behaviour. People are heavily biased 
towards adopting this inside view even when historical information about a situation 
is available (Kahneman & Lovallo, 1993). Alcohol is known to impair cognitive 
processes involved in evaluating risk such as information processing, attention (Dry, 
Burns, Nettelbeck, Farquharson, & White, 2012) and inhibitory control (Field, 
Wiers, Christiansen, Fillmore, & Verster, 2010), and thus is likely to increase risk-
taking behaviour. 
Laboratory studies of risk-taking post-alcohol consumption. 
Experimental research can identify the causal relationship between alcohol 
consumption and increased risk-taking by manipulating and controlling variables via 
objective measures of risk-taking, including measures of gambling and risky driving. 
A number of studies using driving simulators and willingness to drive indicators to 
measure risk-taking behaviour (Table 1), have observed increased risk-taking in 
terms of driving violations under the influence of alcohol relative to placebo 
administration. Other researchers have taken a more decision-making focused 
approach, using gambling tasks such as the Balloon Analogue Risk Task (BART) 
that closely mimic the decision-making processes involved in risk-taking (Lejuez et 
al., 2002).  
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The BART is a high stakes risk task in which participants accumulate $0.05 
for each pump administered to a virtual balloon. Funds are accrued in a temporary 
bank and are only transferred to a permanent store when the participant decides not 
to further inflate the balloon. If the balloon is inflated to the pre-determined 
explosion point (which the participant is unaware of) and explodes, funds accrued 
for that balloon are lost and a new balloon (trial) begins; this is repeated over 30 
trials. Risk is calculated in terms of the average number of pumps entered on trials in 
which the balloon does not explode (adjusted average pumps). Higher number of 
pumps indicates greater risk-taking, as the chances of the balloon exploding increase 
as the number of pumps increases. Results regarding the effect of alcohol on risk-
taking as measured by the BART have been mixed (Table 1). Lejuez et al. (2002) 
showed that risk-taking on the BART is positively correlated with self-reported 
risky behaviours, while Reynolds, Richards, and de Wit (2006) found that 
administering alcohol in an experimental study had no impact on risk-taking relative 
to placebo.  
 The BART has been criticised for excluding trials on which participants are 
riskiest, as the outcome measure is adjusted number of pumps (average number of 
pumps entered across trials on which the balloon did not explode) (Pleskac, 
Wallsten, Wang, & Lejuez, 2008). Pleskac et al. (2008) has since devised an 
automated variation (A-BART) in which the participant types the number of pumps 
they want to administer rather than clicking the mouse to inflate the balloon, thus 
meaning all trials can be included in the outcome measure. The A-BART has been 
determined to be a more accurate measure of risk-taking than the BART, with 
participants willing to take more risks, as well as improved external validity 
(Pleskac et al., 2008). 
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Table 1 
Summary of Findings for Alcohol-Induced Impairment on Risk-Taking and Inhibitory Control. 
 
Cognitive function Study 
 
Design Alcohol dose BrAC Task Statistically 
Significant 
Impairment 
 
 
Risk-taking 
Burian et al. (2002) 
 
Within-subjects, 
placebo controlled 
0.3, 0.5, 0.8 g/kg 0.03, 0.05, 0.09% 
 
Simulated driving Yes 
Burian et al. (2003) Between-subjects 0.5 g/kg 0.048% Simulated driving Yes** 
Weafer & Fillmore 
(2012) 
Within-subjects, 
placebo controlled 
0.65 g/kg 73.7 mg/100ml Simulated driving Yes 
Amlung et al. 
(2014) 
Between-subjects, 
placebo controlled 
0.10g% 0.068% Willingness to 
drive 
Yes* 
Lane et al. (2004) Within-subjects, 
placebo controlled 
0.2, 04, 0.8 g/kg 0.02, 0.04, 0.09 % Risk choice task Yes^ 
Reynolds et al. 
(2006) 
 
Within-subjects, 
double-blind, 
placebo controlled. 
0.4, 0.8g/kg 0.03, 0.07% BART No 
Rose et al. (2014) 
 
Between-subjects, 
placebo controlled 
0.6 g/kg 0.036% BART Yes 
Inhibitory control Weafer & Fillmore 
(2012) 
Within-subjects, 
placebo controlled 
0.65 g/kg 73.7 mg/100ml Cued go-no-go Yes* 
Marczinski et al. 
(2011) 
Between-subjects, 
placebo controlled 
0.65 g/kg 0.089% Cued go-no-go Yes 
 NB: * = Acute tolerance, ^ = dose dependent effect, ** = expectancy bias. 
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Energy Drinks 
Prevalence. It is further speculated that increases in risk-taking post-alcohol 
consumption may be exacerbated by the co-consumption of energy drinks (EDs) 
(Peacock et al., 2015). EDs are caffeinated beverages marketed to reduce fatigue, 
increase alertness and improve performance. Australians are one of the largest 
consumers of EDs globally, with national sales reaching $600 million per annum 
(Cowie & Bolam, 2015). Young people make up the largest consumer group, with 
roughly 37% of 18 to 24 year olds reporting consumption within a three-month 
period (Pennay et al., 2015).  
ED Ingredients. Active ingredients in EDs include caffeine, sugar, taurine, 
glucoronolactone, gurana and B vitamins (Table 2) (Higgins, Tuttle, & Higgins, 
2010). Caffeine and sugar are thought to be the primary agents influencing 
behaviour (Adan & Serra‐Grabulosa, 2010). 
Table 2 
Energy Drink Constituents of Red Bull® 
Constituent Per 250mL 
Sugars 27.5g 
Sodium 100mg 
Taurine 1000mg 
Caffeine 80mg 
Glucoronolactone 60mg 
Inositol 50mg 
Niacinamide 20mg 
Pantothetic Acid 5mg 
Vitamin B6 5mg 
Vitamin B12 5µg 
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Caffeine. One 250ml can of the dominant market brand of ED, Red Bull ©, 
contains 80mg of caffeine, similar to a single cup of instant coffee (Scholey & 
Kennedy, 2004) and 27g of sugar (glucose), higher than regular soft drinks (e.g,. 
Coca-Cola®: 26.5g sugar). Australian ED daily intake guidelines recommend a 
maximum of 500ml (Australian Beverages Council, 2015). Caffeine is the primary 
driver of cognitive and behavioural change (Childs, 2014). Caffeine acts to block the 
sleep promoting adenosine receptor sites in the brain, subsequently reducing fatigue 
and increasing stimulation (Pettenuzzo et al., 2008). Following absorption through 
the gut caffeine reaches its peak plasma levels between 15 and 30 minutes 
(Teekachunhatean, Tosri, Rojanasthien, Srichairatanakool, & Sangdee, 2013). 
Caffeine has been detected in the blood for up to 12 hours post-consumption, but 
effects typically dissipate after four hours (Teekachunhatean et al., 2013). 
Sugar (Glucose). Although caffeine is considered to be the dominant 
constituent of EDs producing cognitive and behavioural effects, glucose also plays a 
considerable role (Childs, 2014). Glucose is essential to brain function, providing its 
major source of energy . Once absorbed into the bloodstream glucose is transported 
across the blood-brain barrier and stored as glycogen in the CNS. Blood glucose 
levels peak around 25-30 minutes post-consumption and remain stable for around 2 
hours before dissipating (Kennedy & Scholey, 2000). Research regarding the effects 
of sugar on cognitive control suggest that high consumption of sugary beverages 
during adolescents may impair neurocognitive processes involved in decision-
making (Reichelt, Killcross, Hambly, Morris, & Westbrook, 2015), while combining 
glucose with caffeine has positive short-term effects for working memory (Giles et 
al., 2012). Glucose and caffeine are reported to have greater psychoactive effects in 
combination than alone (Adan & Serra‐Grabulosa, 2010).  
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 EDs and risk-taking. Evaluations of EDs as a whole have demonstrated 
reduced fatigue (Gershon, Shinar, & Ronen, 2009; Horne & Reyner, 2001), 
improved physical endurance (Ivy et al., 2009), and improved speed of attention 
(Scholey & Kennedy, 2004). However, behavioural effects of ED consumption are 
also of concern given that they are often consumed in excess by young people 
(Gunja & Brown, 2012). Survey data has shown positive associations between ED 
use and increased problem behaviours such as sexual risk-taking, cannabis use, 
fighting, failure to use seatbelts, and cigarette smoking (Miller, 2008). It is yet to be 
determined that EDs are a causal agent in this behaviour and these findings are 
interpreted as indicating that ED consumers are typically riskier and more impulsive 
relative to their non-consumer counterparts 
Consuming EDs has been linked with improved cognitive performance in a 
number of experimental studies, in particular alleviating mental fatigue (Kennedy & 
Scholey, 2004). Consuming 500ml ED was shown to improve driving performance 
relative to baseline in drivers who had just five hours sleep the night prior. ED had 
the greatest effect in the first hour after consumption, an effect that was not observed 
in the sugar matched caffeine-free placebo condition (Horne & Reyner, 2001). Mets 
et al. (2011) later replicated these findings when they specifically tested the effect of 
Red Bull®, concluding that the drink significantly improved driving performance 
and reduced fatigue. This study was financed by Red Bull®, so results should be 
treated with caution. Independently funded studies have also provided support for 
EDs as effective in reducing fatigue for nightshift workers (Jay, Petrilli, Ferguson, 
Dawson, & Lamond, 2006). 
The cued go-no-go task measures response activation and inhibition to a 
target on valid (80%) and invalid orientation cues (20%). The task is further 
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complicated by a stop signal which indicates to the participant to inhibit their 
response; failure to inhibit responses indicates high impulsivity (Marczinski, 
Fillmore, Bardgett, & Howard, 2011). In a study looking at the effects of ED 
consumption on performance, three different ED doses (1.8 ml/kg, 3.6ml/kg and 
5.4ml/kg) were found to significantly improve response activation relative to 
placebo or no drinks, however, there was no significant effect on inhibition 
following valid or invalid cues (Howard & Marczinski, 2010). The cued go-no-go 
task taps into impulsivity as opposed to risk-taking, therefore, inferring risk-taking 
from performance on the cued go-no-go task goes against the idea of impulsivity 
and risk-taking being separate constructs. Experimental research concerning the 
impact of EDs alone on objective measures of risk-taking is limited, instead 
focusing on the combination of EDs with alcohol and subsequent risk behaviour.  
Alcohol mixed with ED (AmED) 
Prevalence and harms. The consumption of alcohol mixed with EDs 
(AmEDs) is a common practice among young Australians aged 18 to 24, with 4.6% 
having consumed AmEDs over a 3-month period. AmED consumers report reasons 
for use such as wakefulness and energy; taste; counteracting the drowsy effects of 
alcohol; facilitating alcohol intoxication, and social bonding for consuming AmEDs 
(Pennay & Lubman, 2012). These motives, patterns of consumption and popularity 
with young people have raised concerns among researchers regarding the safety of 
AmED consumption (Peacock, Bruno, & Martin, 2012; Peacock, Raimondo, & 
Martin, 2013). Self-report data indicates that relative to alcohol only sessions, 
AmED drinking sessions are likely to reduce sedation effects while increasing the 
likelihood of stimulation effects (Peacock et al., 2012). Further research is needed to 
establish the risks associated with AmED when consumed at rates as reported above. 
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Subjective effects. Popular belief is that the caffeine in EDs counteracts the 
adverse effects of alcohol. Retrospective self-report literature indicates that 
consuming AmEDs increases stimulation, energy, and alertness while reducing 
fatigue, clumsiness, confusion and sadness in comparison to when alcohol is 
consumed alone (Peacock et al., 2014). This is despite the fact that AmED and 
alcohol have a similar impact on objective intoxication (Loo et al., 2016). In a recent 
double-blind placebo-controlled study, Loo et al. (2016) reported that sleepiness 
significantly increased after consuming alcohol only (0.08% BrAC), but remained 
stable in the AmED (250ml ED) condition, supporting the “wide-awake 
drunkenness” hypothesis that the stimulative effects of AmED can mask the 
depressive effects of alcohol. Research indicates that consumers of AmEDs 
underestimate their true level of intoxication and thus impairment (Ferreira, De 
Mello, Pompéia, Souza‐Formigoni, & Oliveira, 2006), likely due to the masking 
effect of the ED when mixed with alcohol. This “wide-awake drunkenness” is 
thought to lead to poor decision-making and thus increased likelihood of engaging in 
risky behaviour (Arria & O’Brien, 2011). 
AmED and Risk-Taking. 
Self-report. Between-subjects comparisons of self-report data indicate that trait 
risk-taking is greater among AmED users compared to alcohol-only consumers 
(Peacock et al., 2014). This does not necessarily reflect an effect of the beverage 
though, as the difference may be attributable to a greater tendency towards risk-
taking among AmED consumers relative to alcohol only consumers. Comparison of 
risk-taking within-subjects (i.e. among the same individuals after consuming AmED 
versus alcohol-only) has showed lower risk taking in AmED versus alcohol-only 
drinking sessions (Peacock et al., 2014). This design produces more reliable results 
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in terms of an effect of AmED as individual differences are controlled for by 
comparing participants against themselves. However, self-report data is limited, in 
that confounding factors, such as differences in drinking environment for AmED 
and alcohol sessions and differing frequency of use, cannot be controlled. Indeed, 
previous studies (Peacock et al., 2014) indicate that there may be differences in the 
way AmEDs and alcohol only beverages are consumed (i.e., frequency, quantity and 
environment) that may contribute to this effect.  
Experimental research. Experimental studies are able to control for such 
confounding factors and therefore offer more conclusive data regarding the effects 
of AmEDs on intoxication and risk-taking. An experimental study which directly 
assessed risk-taking using a simulated driving task showed that increasing ED dose 
(1, 2 and 3 250ml cans) mixed with 0.50 and 0.65 g/kg of alcohol did not increase 
risk-behaviours (i.e., speeding or time spent out of lane), relative to the placebo 
condition (Lubman, 2013). Lubman (2013) attributed the lack of a significant effect 
to low sensitivity of the driving simulator as a measure of risk-taking, as a very low 
overall rate of risk-taking was recorded for all participants across conditions. In 
contrast, Peacock et al. (2013) reported a small magnitude yet statistically 
significant effect of ED (3.75ml/kg) on risk-taking as measured by the BART, 
suggestive of increased risk-taking under ED administration independent of alcohol 
dose (0.5g/kg). 
AmED and BrAC. In addition to proposing increased risk-taking, the wide-
awake drunkenness hypothesis also assumes equivalent objective intoxication 
(BrAC) after AmED consumption relative to the same volume of alcohol. However, 
there is some evidence to suggest that BrAC is lower when alcohol is consumed 
with ED compared to when it is consumed with sugar-free mixers. As the quantity 
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of ED is increased BrAC decreases, even when alcohol content is held constant 
(Lubman, 2013). Food digestion is known to decrease the rate of gastric emptying 
which in turn decreases alcohol absorption and thus lowers BrAC (Oneta et al., 
1998). It is likely that the glucose in AmEDs causes such a reaction, causing BrAC 
to be lower in AmED relative to alcohol-only consumers. Empirical support is 
inconsistent, with other studies not having observed such an effect (Loo et al., 2016; 
Marczinski et al., 2011; Peacock et al., 2013), although, these studies used low ED 
doses and thus the difference may not have been of a sufficient magnitude to warrant 
comment. Further research is required to determine the effect of EDs on objective 
intoxication and how this might affect risk-taking. 
 Limitations of current research. Current experimental research is lacking 
in ecological validity. Doses have been limited to one standard 250mL ED in a 
majority of studies (Peacock et al., 2013). Yet survey data indicates that consumers 
are typically drinking 2.4 EDs in a drinking session (Peacock, Raimondo, B & 
Martin, F. H, 2013). Furthermore, laboratory studies generally administer AmED 
doses bolus (in one dose at the start of the session), which is unrealistic given that 
common practice is to pre-load one or two AmEDs in private residences at the 
beginning of the night before attending licensed venues, then drinking more steadily 
throughout the night (Pennay & Lubman, 2012). More research is needed that adopts 
naturalistic dosing protocols which reflect real-world drinking patterns in order to 
assess the behavioural changes and potential resulting harms caused by consuming 
alcohol and ED in excess of recommendations. In addition to problems with 
ecological validity, tasks previously used to measure risk-taking, such as the BART, 
cued go-no-go task and driving simulators, have been criticised as not necessarily 
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measuring the construct and being of low sensitivity (Loo et al., 2016; Lubman, 
2013; Marczinski et al., 2011; Peacock et al., 2013). 
Current Study 
Aims. The aim of the present study was to expand and develop the existing 
AmED and risk-taking literature by implementing a multi-dose naturalistic 
procedure. In order to replicate the real-world rate and quantities of consumption, 
2.5 EDs were administered mixed with 5 standard alcoholic drinks (10g) across four 
doses, the first dose being a double dose, mimicking pre-loading. Previous studies 
have administered alcohol based on body weight (Marczinski et al., 2011; Peacock 
et al., 2013). While this is an accurate formula for determining performance at 
specific BrAC levels, administering standardised drinks to a number of participants 
provides more detail in terms of how standardised doses affect behaviour. After all, 
consumption guidelines are in the form of standard drinks (National Health and 
Medical Research Council, 2009). It is proposed that by administering standard 
doses in a naturalistic pattern results will be more generalizable and thus reflective 
of real-world implications of excessive AmED consumption. 
Risk-taking will be measured by the Automatic Balloon Analogue Risk Task 
(A-BART), with higher number of average pumps and percentage of exploded trials 
indicating risk-taking. The second measure of risk-taking will be the Determination 
Test (DT) component of the Fitness to Drive Standard (DRIVESTA) test set 
(Schuhfried GmbH, 2012). The DT was originally designed as part of a driving 
assessment battery, to measure stress, reactive tolerance. Participants are presented 
with visual and auditory stimuli and must respond by selecting the corresponding 
colour and tone keys on a specially designed key pad and stepping on left and right 
pedals that correspond to icons on the screen. Presentation becomes faster as correct 
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responses accumulate. The task therefore measures participant’s ability to inhibit 
frustration, as indexed by accuracy (% of correct responses) and reaction time (RT) 
risk-taking is characterised by faster RT and lower accuracy of correct responses 
demonstrating inability to inhibit frustration.  
Hypotheses. Based on the ‘wide-awake drunkenness’ premise of increased 
risk-taking post-AmED consumption, the following three hypotheses have been 
formulated. In light of Peacock et al. (2013)’s finding that ED administration 
significantly increased risk-taking on the BART, it was hypothesised that there 
would be a significant Time*Condition interaction for the outcome measure of 
average number of pumps on the A-BART, with minimal differences at the 
ascending limb (35 and 75-minutes), but significantly higher average number of 
pumps (inferring riskier behaviour) recorded at peak caffeine and alcohol levels 
(115 and 155-minutes) in the AmED compared with the alcohol-only condition. A 
significant Time*Condition interaction was hypothesised for median RT on the DT, 
with minimal differences at the ascending limb (25 and 65-minutes), but 
significantly faster RT (inferring riskier behaviour) in the AmED compared to 
alcohol-only condition at peak caffeine and alcohol levels (105 and 145-minutes). 
Previous research has supported faster RTs following AmED administration relative 
to alcohol (Marczinski et al., 2011; Peacock et al., 2013). In theory, speed and 
accuracy are in competition with one-another, thereby, an improvement in one 
should correspond to a deficit in the other evidenced by a speed accuracy trade-off 
(SAT) (Bogacz, Wagenmakers, Forstmann, & Nieuwenhuis, 2010). It was therefore 
hypothesised that there would be a significant Time*Condition interaction for 
accuracy on the DT, with minimal differences on the ascending limb (25 and 65-
minutes), but number of correct responses being significantly lower (inferring riskier 
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behaviour) at peak caffeine and alcohol levels (105 and 145-minutes) in the AmED 
compared with alcohol-only condition. 
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Method 
Participants 
Ethics approval was obtained from the Human Research Ethics Committee 
(Appendix A). The current study was a double-blind, placebo-controlled, within-
subjects design. Thirty participants (n=15 male) aged 18-35 years (the target ED 
demographic) (Gunja & Brown, 2012) were recruited through advertisements posted 
around the University of Tasmania Sandy Bay campus and online (Facebook and 
Gumtree). Participants attended one 60-minute familiarisation session and two 4 
hour experimental sessions in which they consumed 5 standard alcoholic beverages 
with i) ED and ii) placebo. Testing occurred at baseline and five time points, once 
after each drink, and then again as BrAC began to descend. 
 Eligibility was determined by an online screening survey (Appendix C). 
Inclusion criteria included completion of Year 12 or equivalent, normal sleep 
patterns, normal or corrected-to-normal vision and normal Body Mass Index (BMI). 
Participants were regular ED (weekly to monthly); alcohol (≥ 5 standard drinks on 
one occasion in the past month); and caffeine (≥ 5 standard caffeinated products in 
the past week) consumers. Exclusion criteria included history of psychiatric or 
neurological condition, current psychological distress (≥ 30 on the Kessler 
Psychological Distress Scale (K10) (Kessler et al., 2002), intellectual disorder (< 70 
on the Weschler Test of Adult Reading (WTAR) (Wechsler, 2001), alcohol 
dependence (≥ 16 on the Alcohol Use Disorders Identification Test (AUDIT) 
(Saunders, Aasland, Babor, De la Fuente, & Grant, 1993), regular tobacco use (≥ 
weekly), history of drug dependence, illicit drug use (last six months), pregnancy, or 
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any chronic health issues. First-year Psychology students received course credit or 
AUD 80.00; other participants received AUD 80.00. 
Materials and Apparatuses   
 Alcolizer HH-2. BrAC was measured using the Alcolizer HH-2 to determine 
BrAC at the outset of each task. The Alcolizer HH-2 is calibrated to Australian 
certified standards for breathalysers (Alcolizer Technology, n.d). 
Beverage rating scale (BRS). Participants estimated the number of standard 
alcoholic drinks and standard EDs consumed to ensure they were blind to condition 
(Peacock et al., 2013). 
 A-BART. The automatic BART is a computerised risk analysis task in 
which participants inflate a balloon by typing the amount of pumps, accruing $0.05 
per pump in a temporary bank. If the balloon does not explode on the number of 
pumps entered by the participant, the funds in the temporary bank are transferred to 
a permanent tally; if the balloon explodes, the funds are lost. The average breakpoint 
across trials is 64 pumps; the participant is made aware of this explosion point. The 
current study administered 30 trials at each time point. The A-BART can be 
administered in 3.5 minutes (Pleskac et al., 2008).  Response rates on the A-BART 
are moderately correlated with the standard BART (r=.62, p <.01). Scores on the 
BART have been significantly moderately positively correlated with self-reported 
accounts of risky behaviour including alcohol, and substance use, cigarette use, 
gambling, sexual risk behaviour and stealing (Lejuez et al., 2002).  
Determination Test (DT). Participants are presented with five visual 
stimuli; two auditory stimuli and two signals corresponding to foot-operated pedals 
on a screen. The participant must respond as quickly as possible to all signals by 
selecting the corresponding keys on the response panel and foot pedals. The 
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outcome measures are number of correct responses and median RT to correct 
responses. The DT has high internal reliability; construct validity is also high having 
been found to be significantly positively correlated with driving performance 
(Schuhfried GmbH, 2012).  
 Treatment doses. Doses were administered in four beverages, with the first 
being a double dose. The treatment condition consisted of 5 standard serves (33.8ml) 
of a/v Smirnoff Red Label No. 21 vodka, served in standard drink portions, and 
mixed with ED or the equivalent amount of soda water (alcohol-only condition) 
(Table 3). Conditions were matched for taste using Torani sugar-free syrup; previous 
research indicates this technique successfully disguises the taste of ED/placebo 
(Peacock et al., 2013). Alcohol dose was chosen based on drinking habits of young 
people who typically consume 4.2 AmEDs in a drinking session (Pennay & 
Lubman, 2012). Based on pilot testing, it was expected that this dose would achieve 
an average BrAC of 0.05%. Red Bull® was chosen as it is frequently mixed with 
alcohol (Peacock, Raimondo, B & Martin, F. H, 2013). 
Table 3 
Dosing Schedule and Treatment Doses 
Time Estimated 
BrAC 
AmED Condition Alcohol Condition 
0 minutes  0.00% 250ml ED; 67.5 ml 
alcohol 
250ml soda water; 67.5 ml 
alcohol 
40 
minutes  
0.03% 125ml ED; 33.8 ml 
alcohol 
125ml soda water; 33.8 ml 
alcohol 
80 
minutes  
0.04% 125ml ED; 33.8 ml 
alcohol 
125ml soda water; 33.8 ml 
alcohol 
120 
minutes 
0.05% 125ml ED; 33.8 ml 
alcohol 
125ml soda water; 33.8ml 
alcohol 
 
 
22 
 
 
 
Procedure 
 Experimental sessions commenced at 9am or 1pm, four to fourteen days 
apart to ensure familiarisation with tasks was maintained and to limit carry-over 
effects. Condition order was counterbalanced using a completely balanced Latin-
square design. Abstinence requirements prohibited consumption of alcohol and 
caffeine for 24-hours prior to experimental sessions, and food and exercise for 4 
hours, except for a small meal 60-minutes before experimental sessions. Abstinence 
from tobacco and illicit drugs was required for the duration of the study. Prior to 
commencement of experimental sessions, a declaration of abstinence (Appendix E) 
was signed to confirm adherence to pre-session requirements; participants also 
provided written consent (Appendix D) and height and weight measurements. 
Participants completed baseline trials on the A-BART and DT, and were 
tested to ensure BrAC was 0.00%, before commencing the first treatment dose. 
Dosing occurred at 40 minute intervals. Each dose was consumed from an opaque 
bottle over a 10-minute period followed by a 5-minute absorption period. BrAC 
readings were taken at five minute intervals following consumption coinciding with 
task administration (Table 4) 
Table 4 
Timing of Dose and Task Administration 
Dose DT A-BART 
Baseline/No dose Baseline Baseline 
0 mins 25 mins 35 mins 
40 mins 65 mins 75 mins 
80 mins 105 mins 115 mins 
120 mins 145 mins 155 mins 
No dose 195 mins 205 mins 
 
The DT was administered 15 minutes post consumption, and the BART a 
further 10 minutes later (25-minutes post-consumption).The BRS was completed at 
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30 minutes followed immediately by the next dose. After the four doses and 
subsequent testing, the participant observed a 10-minute break to substitute for the 
normal dosing time followed by a final round of testing (DT, BART & BRS). Upon 
completion of testing participants consumed a detoxification meal and were released 
after two consecutive readings of BrAC ≤ 0.03 within a 15-minute period. 
Design and Analysis 
Two participants completed only Session 1 (Alcohol-only). One participant 
completed Session 2 (Alcohol-only) without A-BART testing at Baseline, 35, and 
75-minutes; these subjects were retained in the final analysis. One participant’s DT 
Accuracy scores for Session 1 were excluded as an outlier, falling more than 7 
standard deviations below the mean.  
 The present study used a 2 (Condition: ED, Placebo) x 2 (Session: 1, 2) x 2 
(Sex: Female, Male x 6 (Time: 0 (baseline), 1, 2, 3, 4, 5) within-subjects design. 
Five dependent variables (DT mean RT (ms), DT Accuracy and A-BART average 
number of pumps,average earnings and explosion percentage) were analysed using 
Mixed Models for Repeated Measures in IBM SPSS Statisitics v.21, with an 
unstructured covariance matrix. Session, Condition, Time and Sex were entered as 
fixed effects. BrAC was included as a covariate to control for variation in objective 
intoxication across time and between treatment conditions. Subject was included as 
a random effect to account for performance variation between individuals. Condition 
sequence was determined using a completely balanced Latin-square design based on 
the anticipated sample size of N =30. Only 27 participants completed the study 
meaning that condition administration was not completely balanced. As such, 
session was included as an independent variable to examine the effect of condition 
order. 
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 As the aim of the study was to examine treatment condition effects over 
time, pairwise comparisons for Condition x Time interactions were conducted 
regardless of statistical significance. Pairwise comparisons were also conducted for 
any other interactions that reached significance. All moderate magnitude effects 
(Hedge’s g >0.40) were considered meaningful and interpreted. 
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Results 
Sample Characteristics 
 The sample consisted of young adults with high levels of intellectual 
functioning, with 100% currently completing or having completed post-secondary 
qualifications. AUDIT scores indicated normal alcohol consumption for a young-
adult Australian community sample (7-16) (Bowring, Gouillou, Hellard, & Dietze, 
2013). Two participants reported occasional tobacco use (1 fortnightly; 1 monthly). 
The sample had low levels of psychological distress and normal sleep patterns 
(Table 5). 
Table 5 
Demographic Characteristics (N = 27, 14 male) 
Sample Characteristic Mean (SD) Range 
Age (years) 22.8 (4.2) 18.0-34.0 
BMIa 23.7 (3.0) 19.0-30.0 
Risk for alcohol dependence (AUDIT)b 8.8 (4.2) 2.0-20.0 
General intellectual functioning (WTAR)c  113.3 (9.8) 87.0-127.0 
Level of psychological distress (K-10)d 12.0 (3.1) 8.0-20.0 
Alcohol Sensitivity (ASQ)e 7.3 (2.8) 3.3-14.8 
Sleep patternsf (hours per weeknight) 
                      (hours per weekend night) 
8.0 (0.9) 
8.3 (1.1) 
7.0-10.0 
6.0-10.0 
aThe healthy BMI range is 18.5-24.9; scores ≥ 25.0 are considered overweight and ≥ 
30.0, obese (World Health Organisation, 2006). bThe AUDIT measures alcohol 
dependency. Scores range from 0-40, scores ≥ 16 indicate hazardous drinking 
(Saunders et al., 1993). cWTAR scores <70 indicate below average intelligence; 
scores are normed based on age (Wecshler, 2001). dThe K-10 is a measure of 
psychological distress, scores range from 10-50. Scores ≥ 30 indicate clinical levels 
of psychological distress (Kessler et al., 2002). fEight hours sleep per-night is 
considered to be normal (Hor & Tafti, 2009). 
 
Based on their typical intake, 88% of participants exceeded the 
recommended daily intake for alcohol (>4 standard alcoholic drinks) (National 
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Health and Medical Research Council, 2009) at least once in the past month, while 
11% of participants had exceeded the recommendation for EDs (2 x 250ml EDs/day) 
at least once in the past month (Table 6). 
Table 6 
Self-Report Alcohol, Caffeine and EDs Consumption (N=27) 
Consumption Pattern Mean (SD) Range 
Alcohol (Past Month)     
Average standard alcoholic drinks 
consumed per drinking day 
6.2 (4.9) 1.4-20.0 
Maximum standard alcoholic drinks 
consumed per drinking day 
10.3 (6.0) 2.0-20.0 
Days alcohol consumed 7.7 (6.1) 1.0-26.0 
Days consumed exceeded NHMRC 
guidelines 
2.6 (2.4) 0.0-9.0 
ED Past Month and Caffeine     
Typical ED consumed per drinking day 1.5 (1.2) 0.0-4.0 
Maximum ED consumed per drinking 
day 
2.0 (1.3) 0.0-4.0 
Caffeine intake in the preceding week 
(mg) 
240.0 (181.6) 15.0-673.0 
 
Placebo Manipulation Check 
Beverage rating scale (BRS). A mixed models analysis revealed a 
significant main effect of Condition on perceived alcohol content, F (1, 166) = 
35.42, p <.001, with participants rating alcohol content as higher in the Alcohol-only 
condition (M=3.8, SD=1.1) relative to AmED (M=3.1, SD=1.0), with a moderate 
magnitude effect (g=0.65). The main effect of Condition on perceived ED content 
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was non-significant, F (1,142) = .057, p =.812; participants did not rate ED content 
in the Alcohol-only condition (M 2.01, SD 0.74) as significantly different to AmED 
(M 2.03, SD 0.72), indicating successful blinding to condition. 
Breath Alcohol Content – Automatic-Balloon Analogue Risk Task 
Table 7 
Main Effects and Interactions for Session, Condition, Time and Sex on BrAC 
recorded prior to A-BART administration  
Effect BrAC (A-BART) 
Session F 1, 135 = 19.21, p <.001 
Condition F 1, 182 = 57.40, p <.001 
Time F 5, 70 = 303.95, p <.001 
Sex F 1, 26 = 38.94, p <.001 
Condition*Time F 5, 70 = 3.81, p = .004 
Condition*Sex F 1, 185 = 2.07, p = .152 
Time*Sex F 5, 66 = 34.42, p <.001 
Condition*Time*Sex F 5, 68 = 0.65, p = .662 
 
BrAC. Mixed models for repeated measures analysis revealed significant 
main effects of Session, Condition, Time and Sex for BrAC (%) recorded prior to 
commencing the A-BART. These were subsumed by significant Condition x Time 
and Time x Sex interactions. The Condition x Sex and Condition x Time x Sex 
interactions were non-significant (Table 7). BrAC (%) was significantly higher in 
Session 1 compared to Session 2 (g=0.28). BrAC (%) was significantly higher for 
females than males in the Alcohol-only (p <.001, g= 1.87) and the AmED condition 
(p <.001, g=1.68).              
Pairwise comparisons for the Condition x Time interaction showed that 
BrAC (%) was significantly lower in the AmED relative to the Alcohol-only 
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condition at 35 to 205-minutes. These effects were significant and moderate in 
magnitude (ps<.004, gs>0.56); (Figure 2).
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Figure 2. Mean BrAC and 95% confidence intervals (95%CIs) on the Automatic-Balloon Analogue Risk Task for each of the two treatment 
conditions at six testing time points. NB: Hedge’s gs>0.40 appear in bold. Ps < .050 appear in italics 
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Breath Alcohol Content – Determination Test 
Table 8 
Main Effects and Interactions for Session, Condition, Time and Sex on BrAC 
recorded prior to Determination Test administration 
Effect BrAC (DT) 
Session F 1, 179 = 11.58, p =.001 
Condition F 1, 147 = 44.91, p <.001 
Time F 5, 48 = 409.48, p <.001 
Sex F 1, 9 = 53.00, p <.001 
Condition*Time F 5, 49 = 4.50, p = .002 
Condition*Sex F 1, 146 = 9.55, p = .814 
Time*Sex F 5, 48 = 33.77, p <.001 
Condition*Time*Sex F 5, 49 = 0.71, p = .621 
 
BrAC. Mixed models for repeated measures analysis revealed significant 
main effects of Session, Condition, Time and Sex on BrAC recorded prior to DT 
administration. Significant Condition x Time and Time x Sex interactions were also 
present. Condition x Sex and Condition x Time x Sex interactions were non-
significant (Table 8). BrAC was significantly higher in Session 1 compared to 
Session 2 (g=0.56). BrAC was significantly higher for males than females in the 
Alcohol-only (p<.001, g=2.98) and AmED (p<.001, g=3.55) conditions. 
 Pairwise comparisons for the Condition x Time interaction showed 
significant moderate to large magnitude decreases in BrAC in the AmED relative to 
the Alcohol-only condition at 25 to 195-minutes (ps<.011, gs>0.56; Figure 3).  
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Figure 3.Mean BrAC and 95% confidence intervals recorded prior to Determination Test administration for each of the two treatment conditions 
across six testing time points. NB: Hedge’s gs>0.40 appear in bold. Ps <.050 appear in italics 
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Automatic-Balloon Analogue Risk Task 
Table 9 
Main Effects and Interactions for Session, Condition, Time and Sex on A-BART Average Pumps, Average Earnings and Explosion Percentage 
 
 
 
 
 
 
 
 
 
 
 
NB: All analyses controlled for BrAC. Analysis of Explosion Percentage controlled for baseline (Time 0) differences.
Effect Average Pumps Average Earnings Explosion Percentage 
Session F 1, 211 = 12.21, p = .001 F 1, 222 = 0.01 p = .923 F 1, 192 = 5.89, p = .016 
Condition F 1, 202 = .95, p = .331 F 1, 231 = 0.00, p = .985 F 1, 187 = 0.02, p = .887 
Time F 5, 86 = 2.86 p = .020 F 5, 93 = 1.05, p = .391 F 4, 80 = 2.29, p = .067 
Sex F 1, 28 = 3.26 p = .081 F 1, 30 = 1.60, p = .214 F 1, 35 = 1.00, p = .323 
Condition*Time F 5, 66 = 0.80, p = .554 F 5, 81 = 2.17, p = .066 F 4, 66 = 2.01, p = .104 
Condition*Sex F 1, 202 = 0.62, p = .431 F 1, 251 = 4.64, p = .032 F 1, 185 = 0.90, p = .323 
Time*Sex F 5, 71 = 1.57, p = .181 F 5, 92 = 2.02, p = .083 F 4, 64 = .1.32, p = .272 
Condition*Time*Sex F 5, 61 = 0.72, p = .613 F 5, 74 = 2.17, p = .067 F 4, 68 = 1.98 p = .107 
3
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Average number of pumps. Mixed models for repeated measures analysis 
controlling for BrAC recorded prior to the task revealed significant main effects of 
Session and Time for average number of pumps. Main effects of Condition and Sex 
were not statistically significant. The Condition x Time, Condition x Sex, Time x 
Sex and Condition x Time x Sex interactions were also not statistically significant 
(Table 9). Average number of pumps was significantly higher in Session 2 compared 
to Session 1, with only a small magnitude effect (g= 0.23). 
Pairwise comparisons of the Condition x Time interaction (Figure 4) revealed 
small magnitude differences which did not reach statistical significance in Average 
number of pumps between AmED and Alcohol-only conditions at all of the six time 
points. Pairwise comparisons of the Time x Sex interaction revealed that Average 
Number of Pumps were higher for males than females at time 3 and 4 (ps≤.040, 
gs≥0.56).
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Figure 4. Mean Average Number of Pumps and 95% confidence intervals (95% CI) on the Automatic Balloon Analogue Risk Task for each of 
the two conditions at six testing time points. NB: Hedge’s gs>0.40 appear in bold. Ps < .050 appear in italics 
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 Percentage of exploded trials. Mixed models for repeated measures analysis 
controlling for BrAC recorded prior to the task and Baseline performance revealed a 
significant main effect of Session for percentage of explosions. Main effects of 
Condition, Time and Sex were non-significant. Condition x Time, Condition x Sex, 
Time x Sex and Condition x Time x Sex interactions were all non-significant (Table 
9). Percentage of explosions were higher in Session 2 than Session 1 (g=0.31). 
 Pairwise comparisons for the Condition x Time interaction revealed that a 
significant moderate magnitude increase in Percentage of Explosions was 
significantly higher in the Alcohol-only relative to AmED condition at 75-minutes 
(Figure 5). No other time points reached significance.  
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Figure 5. Mean Percentage of Exploded Trials and 95% CI on the Automatic Balloon Analogue Risk Task for each of the two conditions at six 
testing time points. NB: Hedge’s gs≥0.40 appear in bold, ps≤.050 appear in italic
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 Earnings. Mixed models for repeated measures analysis controlling for 
BrAC recorded prior to the task revealed non-significant main effects of Session, 
Condition, Time and Sex on earnings. A significant Condition x Sex interaction was 
revealed but the Condition x Time, Time x Sex and Condition x Time x Sex 
interactions were all non-significant (Table 9) 
 Pairwise comparisons of the Condition x Time interaction revealed a 
significant moderate magnitude increase in average earnings in the Alcohol-only 
condition relative to AmED at 35-minutes (Figure 6). Comparisons at all other time 
points were not statistically significant and of small magnitude. Pairwise 
comparisons of the Condition x Sex interaction revealed that Average Earnings were 
significantly higher for males than females in the Alcohol-only condition (p=.035, 
g=0.61). No significant sex differences were observed in the AmED condition 
(p=.953, g=0.02).  
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Figure 6. Mean Earnings and 95% confidence intervals on the Automatic-Balloon Analogue Risk Task for each of the two treatment conditions 
at six testing time points. NB: Hedge’s gs>0.40 appear in bold. Ps <.050 appear in italics
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Determination Test 
Table 10 
Main Effects and Interactions for Session, Condition, Time and Sex on 
Determination Test Accuracy and RT  
Effect Accuracy (% correct) RT (seconds) 
Session F 1, 216 = 5.42, p = .021 F 1, 159 = 313.14 p < .001 
Condition F 1, 154 = 0.23, p = .634 F 1, 201 = 20.00, p < .001 
Time F 5,74 = 2.08, p = .077 F 5, 106 = 3.64 p = .004 
Sex F 1, 23 = 7.12 p = .013 F 1, 27 = 1.04, p = .316 
Condition*Time F 5, 61 = 1.06, p = .931 F 5, 64 = 4.43, p = .002 
Condition*Sex F 1, 151 = 7.71, p = .006 F 1, 205 = 1.05, p = .306 
Time*Sex F 5, 73 = 1.06, p = .387 F 5, 61 = 3.16, p = .012 
Condition*Time*Sex F 5, 60 = 1.13, p = .357 F 5, 61 = 0.91, p = .482 
 
Accuracy. Mixed models for repeated measures analysis controlling for 
BrAC recorded prior to the DT revealed significant main effects of Session and Sex 
for accuracy, as well as a significant Condition x Sex interaction. Main effects of 
Condition and Time were non-significant, as were the Condition x Time, Time x Sex 
and Condition x Time x Sex interactions (Table 10). Accuracy was significantly 
higher in Session 2 compared to Session 1 (g= 0.16). 
Pairwise comparisons for the Condition x Time interaction showed non-
significant small magnitude differences between Alcohol-only and AmED at all six 
time points (Figure 7). Pairwise comparisons of the Condition x Sex interaction 
showed that females were significantly more accurate than males in both the 
Alcohol-only (p =.039, g=0.58) and the AmED (p =.003, g=0.84) conditions.  
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Figure 7. Mean Accuracy Percentage and 95% CI on the Determination Test for each of the two conditions across the six testing time points. 
NB: Hedge’s gs>0.40 appear in bold. Ps < .050 appear in italics
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RT. Mixed models for repeated measures analysis controlling for BrAC 
recorded prior to the DT revealed significant main effects of Session, Condition and 
Time for RT. The Condition*Time and Time*Sex interactions were also significant. 
The main effect of Sex and the Condition*Sex interaction were non-significant 
(Table 10). RT was significantly faster in Session 2 than Session 1 (g=0.01). 
Pairwise comparisons of Condition x Time interaction revealed that RT was 
significantly faster in the AmED relative to Alcohol-only condition at 25-145-
minutes (Figure 8), although only a small magnitude decrease was observed at 25 
and 65-minutes. Breakdown of the Time*Sex interaction revealed no significant 
differences between sexes at any of the six testing time points, however significant 
differences were observed between time points among females (Table 13) and males 
(Table 14) separately.  
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Figure 8.  Median Reaction Time (seconds) and 95% CI on the Determination Test for each of the two treatment conditions across the six testing 
time points. NB: Hedge’s gs>0.40 appear in bold. Ps < .050 appear in italics 
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Discussion 
The present study examined the effects of AmED consumption on risk-taking 
behaviour relative to alcohol-only consumption, extending on existing work by 
replicating real-world drinking practices through a multi-dosing, standardised 
procedure in which all participants received the same alcohol and ED doses, typical 
of those served in a licensed venue. Results supported the hypothesis that there 
would be a significant Condition x Time interaction on RT on the DT, with RT being 
significantly faster in the AmED relative to the alcohol-only condition, at peak 
caffeine and alcohol levels (105 and 145-minutes). The hypothesis that accuracy 
would be significantly lower in the AmED relative to alcohol-only condition at peak 
caffeine and alcohol levels, as evidenced by a significant Condition x Time 
interaction, was not supported, with no significant differences in accuracy between 
AmED and alcohol-only at any of the six testing time points. Finally, the hypothesis 
that there would be a significant Condition x Time interaction on average number of 
pumps on the A-BART, with number of pumps being significantly higher in the 
AmED relative to alcohol-only condition at peak caffeine and alcohol levels was not 
supported, there were no significant differences between conditions at any of the six 
testing time points. Although there was some evidence of increased risk-taking as 
measured by other possible indices of risk-taking for the A-BART  
BrAC 
 Mean BrAC was significantly lower after ingesting AmED relative to 
Alcohol-only at all active time points (Time 25-195 minutes) at both DT and A-
BART administration. This result is consistent with past research demonstrating 
lower objective intoxication following consumption of moderate to large ED doses 
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with alcohol relative to alcohol-only (Lubman, 2013). This discrepancy between 
treatment conditions is likely due to the influence of sugar in the ED slowing the rate 
of gastric emptying, thus decreasing alcohol absorption and lowering BrAC (Oneta 
et al., 1998). Future studies should make sure to control for BrAC to rule out this 
explanation for changes in performance, and consider use of sugar-matched placebos 
for ecological validity, given that most non-ED alcohol mixers (e.g., Coca-cola) 
typically contain sugars. 
Session 
 There was a significant main effect of session on RT, Accuracy, Average 
Pumps and Earnings. Performance improved from session 1 to session 2 indicating 
practice effects, despite effective counterbalancing of condition order. Falleti, 
Maruff, Collie, and Darby (2006) showed that RT on the CogState Battery, which 
assesses RT and accuracy on various tasks, was highly susceptible to practice effects, 
while accuracy was moderately correlated on test-retest trials, it is therefore 
important to control for the effect of session. While practice effects were observed in 
the current study, there were no differential carryover effects (i.e., Session x 
Condition or Session x Time interactions), therefore, the effect of learning was 
consistent regardless of whether the initial session was Alcohol-only or AmED. 
Determination Test 
RT. AmED consumption produced consistent improvements in RT relative 
to alcohol-only after controlling for BrAC. Exceeding maximum recommended daily 
intake for ED produced larger effects, with condition differences reaching moderate 
to large magnitude effects at 105-minutes (post ingestion of 500ml) and 145-minutes 
(post ingestion of 625ml). This finding is consistent with previous research (Peacock 
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et al., 2015) that administered ED doses of 500ml and 750ml. Results such as these 
suggest that consuming ED in combination with alcohol improves cognitive 
performance relative to Alcohol-only, at least in terms of RT.  
The current study observed significantly faster RTs at 25mins and 65mins in 
the AmED relative to alcohol-only condition, when ED doses were 1.5 (375ml), and 
2 (500ml) standard EDs, respectively. This indicates that consumers do not need to 
consume EDs in excess of guidelines for there to be an impact on the cognitive 
effects of alcohol. While the current study administered moderate alcoholic doses (5 
standard drinks, mean peak BrAC 0.05%), Peacock et al. (2015) dosed participants 
to reach a BrAC of 0.08%, demonstrating that improved RT under AmED is 
persistent at higher alcoholic doses. 
 Accuracy. AmED administration did not significantly impact accuracy 
relative to alcohol-only. It was expected that in the current study increased risking-
taking would be evidenced by a SAT on the Determination Test measures. The SAT 
proposes that speed and accuracy are competing demands, therefore if speed is to 
increase accuracy will suffer (Bogacz et al., 2010). As hypothesised RT was faster 
under AmED, however there was no corresponding decrease in accuracy. This result 
is in contrast to previous findings which showed that AmED decreased the amount 
of errors made during the ascending limb on the Digit Symbol Substitution Task 
(DSST) following 500ml and 750ml ED doses, whilst RT was also improved. 
However, accuracy following a 750ml ED AmED dose was not significantly 
different to alcohol-only at peak intoxication (0.08% BrAC), with a significant yet 
small magnitude decrease on the descending limb (Peacock et al., 2015).  
In the current study, participants consumed an accumulative total of 625ml (2.5) 
ED by the final dose, alcohol administration was also accumulative, and BrAC did 
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not peak until 145-minutes. It is therefore possible that ED doses were too low 
during the ascending limb for improvements in accuracy to occur and, by the time 
the ED consumption peaked at 625ml (195-minutes), participants were also at peak 
alcohol intoxication (0.05% BrAC), therefore they were too intoxicated for ED to 
have an attenuating effect. Furthermore, no significant difference in accuracy 
between AmED and Alcohol-only was observed when BrAC had begun to decrease 
(195-minutes) because ED dose had exceeded the point at which performance 
enhancing effects can be seen on the descending limb (500ml) (Peacock et al., 2015). 
Although no effects of condition were observed, sex did differentially affect 
accuracy, with females performing significantly better than males at all time points. 
This is in contrast to recent findings that show males to be more accurate than 
females on various measures of multi-tasking (Mäntylä, 2013), as the DT requires 
participants to respond to colour, tone, direction and orientation, performance on this 
task might be likened to multi-tasking. However, the task was used specifically for 
its ability to assess frustration tolerance in relation to risk-taking. High levels of 
testosterone in males contribute to impatient and irritable behaviours that are 
counter-productive to inhibition of frustration (Olweus, Mattsson, Schalling, & 
Loew, 1988), explaining why they might perform poorly on the DT task.  
Automatic-Balloon Analogue Risk Task 
Average pumps. Risk-taking propensity, as measured by average number of 
pumps on the A-BART, was not significantly increased by AmED consumption 
relative to alcohol-only. These results contradict self-reported drinking behaviour: 
Woolsey, Waigandt, and Beck (2010) found that risk-taking was increased when 
consumers had AmED compared to alcohol-only, whereas, Peacock et al. (2014) 
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found that self-reported risk-taking was lower when AmED was consumed, relative 
to alcohol-only. 
Average number of pumps in the present study were not altered by alcohol 
administration regardless of condition, as evidenced by the non-significant main 
effect of Time. Experimental research regarding the impact of alcohol on risk-taking 
is mixed. Researchers such as Lane, Cherek, Pietras, and Tcheremissine (2004) and 
Rose, Jones, Clarke, and Christiansen (2014) observed increased risk-taking 
propensity on decision making tasks in alcohol (0.02, 0.04 & 0.09 BrAC% and 0.036 
BrAC %, respectively) vs placebo conditions whereas, others saw no such effects 
when BrAC% ranged from 0.03% up to 0.12% (George, Rogers, & Duka, 2005; 
Reynolds et al., 2006). The lack of effect in the current study might be attributable to 
low alcoholic doses. Previous studies have dosed participants to reach a BrAC of 
0.08% (Lane et al., 2004; Rose et al., 2014), while peak BrAC in the current study 
was 0.05%. The alcohol dose administered in the current study may not have been 
sufficient to induce impairment to a meaningful degree. 
Despite being significantly correlated with self-reported risk-taking and 
substance use, (Lejuez, Aklin, Zvolensky, & Pedulla, 2003), the A-BART itself may 
not be sufficient to detect risk-taking. The original BART has been criticised for 
potentially biasing participants’ risk-taking downwards: due to repetition participants 
often administer a low number of pumps in order to complete the task faster, 
(Pleskac et al., 2008). The BART is further criticised for potential practice effects 
(DeMartini et al., 2014). The A-BART improves on the standard BART by limiting 
biases towards under-reporting of risk. Furthermore, the A-BART performs better on 
measures of external validity with correlations improving on measures of sensation 
seeking r = .28 to r =.33 and impulsivity r =.06 to r =.17 (Pleskac et al., 2008).  
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Despite its improvements on the original design, participant responses on the A-
BART can be influenced by the task itself. For instance, if a participant enters a 
certain number of pumps and the balloon explodes, this may increase cautiousness in 
one person or risk-taking in another. A successful run of consecutive high pumps 
without an explosion may encourage further application of a higher number of 
pumps whereas, an explosion may deter high pumps despite previous success 
(Humphries, 2016). For instance, Euser, Van Meel, Snelleman, and Franken (2011) 
administered 60 BART trials in 20 trial blocks and found that participants in alcohol 
and placebo conditions modified their strategies based on outcomes in the initial 
block of trials. Participants in the placebo condition were more cautious to begin 
with whereas, those in the alcohol condition started out quite risky then reigned in 
their behaviour to become more cautious over time. Therefore, simply averaging 
number of pumps, earnings or percentage of explosion may not be sufficient to 
determine an individual’s overall risk-taking propensity (Humphries, 2016). 
Although characteristics of the task may influence performance, there is no reason to 
suspect that they would have differentially affected AmED versus Alcohol-only 
sessions in the current study. Furthermore, the current study controlled for Session in 
order to minimise the impact of such factors.  
Whilst AmED did not increase average number of pumps on the A-BART, there 
was an effect of sex, with males entering significantly higher number of pumps than 
females at 115-minutes and 155-minutes post-consumption. Given that BrAC peaked 
for both males and females at 155-minutes, this result indicates a trend towards 
greater risk-taking on the A-BART at peak intoxication in males that is not present 
for females. This is consistent with poorer frustration tolerance among males 
(Olweus et al., 1988) as indicated by lower accuracy on the DT reported above. 
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Psychometric testing of the A-BART revealed that females are in fact more risk 
averse on this task than males (Pleskac et al., 2008). Literature on sex differences in 
risk-taking indicates that males are generally riskier than females, particularly in 
younger generations (Byrnes, Miller & Schafer, 1999). Taken together these results 
have real-world implications in terms of males being riskier when drinking. Given 
that analyses of results from the current study returned no significant Time x 
Condition x Sex interactions, sex effects were consistent regardless of alcohol-only 
or AmED administration. 
Earnings and explosion percentage. Although there was no consistent effect of 
condition on earnings or explosions in the current study there was a significant 
difference at 35-minutes with earnings being higher in the alcohol-only condition 
and at 75-minutes with earnings being higher in the AmED condition. Caffeine 
peaks between 15 and 30 minutes’ post consumption (Teekachunhatean et al., 2013), 
coinciding with administration of the A-BART at time one (35mins), theoretically 
AmED could be impacting risk-taking propensity at this time.  
Lower earnings tend to indicate less risk-taking, however, there was no 
significant difference in percentage of explosions between conditions at 35mins. A 
significant difference was observed at 75-minutes though, with percentage of 
explosions being higher in the alcohol-only condition, corresponding to the 
significant difference in earnings at 75-minutes. Higher earnings should be indicative 
of higher number of pumps and thus greater risk taking. Indeed, DeMartini et al. 
(2014) observed earnings on the BART increase in line with number of pumps, 
while the number of explosions decreased. Therefore, higher earnings in the AmED 
condition at 75-minutes could be indicative of greater risk-taking. Although average 
number of pumps is the primary measure of risk-taking for the A-BART, these 
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findings justify further work investigating whether other outcomes might also be 
sensitive indices of risk-taking, looking at the associations with other objective 
laboratory based measures and real-world risk-taking. 
Sex differences were once again evident with a significant effect on earnings, 
with males earning significantly more than females in the alcohol-only condition. 
This result is unsurprising given the sex effect on average number of pumps, as total 
earnings are influenced by the number of pumps administered (DeMartini et al., 
2014; Pleskac et al., 2008). This result can also be interpreted in light of the 
significant effect of condition on RT. RT was significantly faster in the AmED 
condition relative to alcohol-only, suggesting that cognitive performance is actually 
improved under AmED administration, which may account for the lack of a sex 
effect on earnings under AmED. However, it is also likely that differences are 
attributable to the fact that females tend to be more risk averse than males on the A-
BART (Pleskac et al., 2008). 
Implications 
 Although participants typically did not demonstrate increased risk-taking 
under AmED administration in terms of decision making on the A-BART, 
reductions in RT following AmED ingestion, may cause individuals to underestimate 
alcohol-induced impairment, as consumers judge their level of intoxication on 
various cognitive abilities (Celio et al., 2014). Improvements in RT were observed in 
the current study when controlling for BrAC. This underestimation may lead to 
increased likelihood of adverse events, such as accidental injury. Leong (in press) 
found that participants rated their ability to drive as better under AmED compared to 
alcohol-only administration when BrAC was controlled for. Although this does not 
indicate intent to drive, this result is concerning as consumers perceive their overall 
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cognitive functioning as better than relative to alcohol-only. In addition, 
improvements in RT following ingestion of AmED relative to alcohol could predict 
lower subjective intoxication (Celio et al., 2014), and thus increased consumption 
and prolonged drinking sessions. 
 Whilst RT was attenuated under AmED administration in the current study 
Bellamy (in press) found that consuming 500ml of ED did not improve RT relative 
to placebo. This discrepancy is likely due to the cognitive state of participants at the 
time of ED administration. A the current study combined alcohol with ED it is likely 
that attenuation of RT is due to participants being cognitively impaired due to the 
adverse effects of alcohol whereas, participants in Bellamy’s (in press) study were 
sober and well rested thus they were unimpaired at time of ED administration. 
Research suggests that fatigue caused by 24 hours of sleep deprivation causes 
cognitive impairment equivalent to that seen at 0.10% BrAC (Dawson & Reid, 
1997). Previous studies have found EDs to be helpful in reducing fatigue (Jay et al., 
2006; Kennedy & Scholey, 2004). Therefore, if ED can relieve fatigue and fatigue 
induces similar impairments to alcohol, then the fact that ED reduced alcohol 
induced impairment in terms of RT in the current study is not surprising.  
 The implementation of real-world drinking practices in dose administration 
makes these results generalizable to a community context. What this shows is that 
AmED consumers are likely to have better RT and hence these cues may lead them 
to misperceiving their level of intoxication when drinking at moderate levels, thus 
causing them to drink more. Consistent with field research by Peacock et al. (2012) 
participants in the current study were no more risky following AmED consumption 
than when they had alcohol-only. 
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Limitations and Directions for Future Research 
While AmED doses reflected those consumed naturalistically (Peacock, 
Raimondo & Martin, 2013; Pennay et al., 2015), the current study does not account 
for the impact that other alcoholic beverages consumed in addition to AmEDs might 
have on risk-taking. Peacock et al. (2013) found that AmEDs made up less than half 
of the alcoholic drinks consumed in drinking sessions. In addition, experimental 
conditions would have limited the impact that drinking environment and social 
interaction might have on risk-taking in the real-world, limiting ecological validity 
and thus generalisability. Although not necessarily a limitation it should be noted 
that BrAC peaked at 0.05% which is essentially the legal driving limit in Australia. It 
is possible that larger doses may elicit greater risk-taking however, the aim of the 
study was to measure risk-taking at moderate AmED doses. 
The lack of effect of AmED on risk-taking may be attributable to low sensitivity 
of tasks. As previously discussed, critics of the A-BART claim that the outcome 
measures of average number of pumps, earnings and percentage of explosions are 
insufficient to determine risk-taking propensity. In addition, it is unclear whether the 
Determination Test was difficult enough to elicit a SAT, as RT was improved but 
accuracy was unaffected under AmED administration. Assessing measures using 
more complex models that take into account detailed aspects of performance, such as 
consecutive wins on the A-BART (Humphries, 2016), would enable thorough 
measurement of risk-taking. Finally, abstinence from caffeine and food prior to 
testing may have exacerbated the effects of the caffeine and sugar in the ED. 
Caffeine is sensitive to reinstatement effects, meaning that administration following 
abstinence predicts a return to base-line functioning (Rogers et al., 2005). Therefore, 
poorer performance in the alcohol-only condition would be due to caffeine 
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withdrawal. This would likely be the case in caffeine dependant individuals (Rogers 
et al., 2005) however, this effect cannot be assessed in the current study as 
dependence and withdrawal were not measured. 
While it can be inferred that a misperception of degree of intoxication due to 
improved cognitive function (faster RT) might increase the likelihood of adverse 
events, the current study found no direct effect of AmED on risk-taking. In addition, 
while the companion study found that participants rated their ability to drive as better 
in the AmED relative to alcohol-only study (Leong, in press), intent to drive was not 
assessed. Future research should aim to test whether underestimation of intoxication 
really does lead consumers to engage in risky behaviours such as drink driving. 
Testing AmED consumers in informal environments would enable examination of 
associations between objective cognitive impairments and actual risk-taking 
behaviours. Ecological momentary assessment (EMA) has been used in clinical 
research to assess participants’ behaviours in real time in their natural environment 
(Shiffman, Stone, & Hufford, 2008). By administering cognitive behavioural tasks 
via electronic devices, with real time self-reports of alcohol consumption and risk-
taking, and objective assessments of BrAC via wearable alcohol biosensors, EMA 
could examine the relationship between intoxication, objective cognitive 
performance and actual risk-taking. 
Conclusion 
The present study examined the effects of AmED administration on risk-
taking at moderate naturalistic doses. Results revealed that AmED administration did 
not typically increase risk-taking as measured by the A-BART. However, a trend 
towards greater risk-taking on the ascending BrAC limb, was evidenced by 
significantly higher earnings in the AmED relative to alcohol-only condition at 75-
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minutes. Furthermore, AmED ingestion did improve cognitive function in terms of 
RT, which could potentially impact AmED consumers ability to gauge their level of 
intoxication. If consumers are feeling as though they are performing better 
cognitively, they are likely to misperceive how drunk they are (Celio et al., 2014). 
For consumers, perceiving themselves as less intoxicated relative to alcohol-only 
could impair their ability to judge risk and thus increase the likelihood of adverse 
events, such as accidental injury, occurring. Therefore, consuming AmED may 
increase the possibility of risk-taking compared to consuming alcohol-only. 
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Appendix B 
Online Screening Questionnaire 
 
School of Medicine (Psychology) - On-line Surveys (surveys.psychol.utas.edu.au) 
 
2016 Honours Alcohol & Energy Drinks Screening Questionnaire 
Thank you for your interest in participating in this research. The purpose of this 
study is to investigate the impact of alcohol, with and without energy drinks, on 
cognitive performance through measurement of behavioural outcomes. 
Participation will involve attending one 60 minute familiarisation session and four 
270 minute experimental sessions at the Psychology Research Centre, Hobart 
campus, University of Tasmania.  In each experimental session participants will 
consume one beverage containing a maximum of three standard 250mL energy 
drinks, and/or a maximum of six standard alcoholic drinks.  Participants will then 
complete computerised behavioural laboratory tasks.  Breath alcohol concentration 
(BrAC) & Blood glucose levels will be monitored and participants will complete 
several scales assessing their feeling of intoxication and impairment.  At the end of 
each session, participants will remain at leisure at the Psychology Research Centre 
until two consecutive BrAC measurements of 0.03% or less are recorded.  Upon 
completing the final session, participants will be reimbursed $160 (KHA111/112 
students will receive up to 8 hours research credit plus monetary reimbusement for 
the remaining hours). 
We are currently seeking healthy participants who: 
Are male OR female 
Are aged 18-35 
Have English as a first language 
Have completed Year 12 
Have normal or corrected-to-normal vision 
Have normal sleep patterns 
Have no history of any significant neurological condition, including epilepsy 
Have no significant current physical condition 
Have no current diagnosis of a significant psychological condition or intellectual 
disability 
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Have consumed an energy drink in the last month 
Regularly consume caffeine (e.g., tea, coffee, chocolate) 
Regularly consume alcohol 
Are not regularly taking prescription medication 
Are not currently using illicit drugs 
Are able to attend the Hobart campus of the University of Tasmania for one 60 
minute session and four 270 minute sessions, beginning at 9am or 1pm. 
If you are still interested and eligible to participate in this research, please complete 
the following online screening questionnaire.  Please note that all information will be 
kept confidential and securely stored.  You can close this browser window at any 
point during the questionnaire if you are no longer interested in participating. 
Once again, thank you for your interest in our research. We appreciate your 
assistance. 
There are 65 questions in this survey 
Demographics and Contact Details 
[]What is your current age in years? * 
Only numbers may be entered in this field. 
 
Please write your answer here: 
  
[]What is your sex? * 
Please choose only one of the following: 
 Female 
 Male 
[]Is English your first language? * 
Please choose only one of the following: 
 Yes 
 No 
[]Are you currently studying KHA111 Psychology A or KHA112 Psychology B and seeking 
research participation credit? * 
Please choose only one of the following: 
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 Yes 
 No 
[]What was the highest grade of school you completed? * 
Please choose only one of the following: 
 Grade 6 
 Grade 7 
 Grade 8 
 Grade 9 
 Grade 10 
 Grade 11 
 Grade 12 
 Grade 13 
 Other  
  
[]Are you currently studying for any further qualification(s)? * 
Please choose only one of the following: 
 Yes 
 No 
[]If yes, what qualification(s) are you currently studying for? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '6 [q15]' (Are you currently studying for any 
further qualification(s)?) 
Please choose all that apply: 
 Trade Certificate 
 Other Certificate (e.g., TAFE, Cert III) 
 Associate or Undergraduate Diploma 
 Bachelor Degree 
 Graduate Diploma/Certificate 
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 Honours Degree 
 Postgraduate Degree 
Other:  
  
[]Have you completed any further qualifications? * 
Please choose only one of the following: 
 Yes 
 No 
[]What further education qualifications have you completed? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '8 [q152]' (Have you completed any further 
qualifications?) 
Please choose all that apply: 
 Trade Certificate 
 Other Certificate (e.g., TAFE, Cert III) 
 Associate or Undergraduate Diploma 
 Bachelor Degree 
 Graduate Diploma/Certificate 
 Honours Degree 
 Postgraduate Degree 
Other:  
  
[] 
What driver licence do you currently hold? * 
Please choose only one of the following: 
 No driver licence 
 Learner licence 
 Provisional P1 licence 
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 Provisional P2 licence 
 Full licence 
 Other  
  
[] 
What is your email address? 
Please write your answer here: 
  
[]What is the phone number which you are most easily reached on? * 
Please write your answer here: 
  
Medical History 
[]Do you have any difficulties with vision? * 
Please choose only one of the following: 
 Yes 
 No 
[] 
If yes, are these difficulties corrected (i.e., glasses/contacts)? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '13 [q21]' (Do you have any difficulties with vision?) 
Please choose only one of the following: 
 Yes 
 No 
[] 
Do you have a sleep disorder or any sleeping difficulties? * 
Please choose only one of the following: 
 Yes 
 No 
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[]On average, how many hours do you sleep on a: * 
Please write your answer(s) here: 
Weeknight 
  
Weekend 
  
[]Do you work night shifts (e.g., 10pm until 6am)Â or double shifts (e.g., 8am until 
midnight)? * 
Please choose only one of the following: 
 Yes 
 No 
[]If yes, how many times per week do you work night shifts/double shifts? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '17 [q24]' (Do you work night shifts (e.g., 10pm until 
6am)Â or double shifts (e.g., 8am until midnight)?) 
Only numbers may be entered in this field. 
 
Please write your answer here: 
  
[]Have you ever had or are you now suffering from any of the following? * 
Please choose the appropriate response for each item: 
  Yes Uncertain No 
Fits or convulsions 
   
Epilepsy 
   
Regular giddiness 
   
Concussion 
   
Severe head injury 
   
Loss of consciousness 
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  Yes Uncertain No 
Diabetes 
   
Hypertension 
   
Gastro-oesophageal reflux condition 
   
Heart condition 
   
Substance abuse/dependence disorder 
   
[]Do you have any other serious physical conditions? * 
Please choose only one of the following: 
 Yes 
 No 
[]Are you currently suffering from anxiety or depression? * 
Please choose only one of the following: 
 Yes 
 No 
[]Do you have any other serious mental health condition? * 
Please choose only one of the following: 
 Yes 
 No 
[] 
What is your approximate height in cm? Note that 1 foot = 30.5cm. Please write 'don't 
know' if not sure. * 
Please write your answer here: 
  
[]What is your approximate weight in kg? Please write 'don't know' if not sure. * 
Please write your answer here: 
  
K10 
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[] 
These questions concern how you have been feeling over the past 30 days. Please indicate 
the response which best represents how you have been. Please be assured your answers 
will remain confidential. 
During the last 30 days, about how often did you feel tired out for no good reason? * 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
[]During the last 30 days, about how often did you feel nervous? * 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
[]During the last 30 days, about how often did you feel so nervous that nothing could calm 
you down? * 
Only answer this question if the following conditions are met: 
Answer was 'All of the time' or 'Most of the time' or 'Some of the time' or 'A little of 
the time' at question '26 [r279q0]' (During the last 30 days, about how often did you 
feel nervous?) 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
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[]During the last 30 days, about how often did you feel hopeless? * 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
[]During the last 30 days, about how often did you feel restless or fidgety? * 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
 
 
[]During the last 30 days, about how often did you feel so restless that you could not sit 
still? * 
Only answer this question if the following conditions are met: 
Answer was 'All of the time' or 'A little of the time' or 'Some of the time' or 'Most of 
the time' at question '29 [q35]' (During the last 30 days, about how often did you feel 
restless or fidgety?) 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
[]During the last 30 days, about how often did you feel depressed? * 
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Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
[]During the last 30 days, about how often did you feel that everything was an effort? * 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
[]During the last 30 days, about how often did you feel so sad that nothing could cheer you 
up? * 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
[]During the last 30 days, about how often did you feel worthless? * 
Please choose only one of the following: 
 None of the time 
 A little of the time 
 Some of the time 
 Most of the time 
 All of the time 
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Caffeine Use 
[]Have you consumed any caffeinated products in the last WEEK (e.g., tea, coffee, 
chocolate drinks, cola, chocolate, energy drinks)? * 
Please choose only one of the following: 
 Yes 
 No 
[]How many caffeinated products would you have consumed in the last WEEK (e.g., two 
coffees and one tea = 3)? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '35 [q41]' (Have you consumed any caffeinated 
products in the last WEEK (e.g., tea, coffee, chocolate drinks, cola, chocolate, 
energy drinks)?) 
Only numbers may be entered in this field. 
 
Please write your answer here: 
[]How many times on average in a DAY do you eat/drink the following caffeine-containing 
products, from the time you wake up until the time you fall to sleep (e.g., 2 x 220ml tea = 
2)? 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '35 [q41]' (Have you consumed any caffeinated 
products in the last WEEK (e.g., tea, coffee, chocolate drinks, cola, chocolate, 
energy drinks)?) 
Please write your answer(s) here: 
Instant coffee (220mL)  
Instant coffee decaffeinated (220mL)  
Ground coffee long black style (220mL)  
Ground coffee cappuccino style (220mL)  
Ground coffee expression style (30mL)  
Decaffeinated ground coffee (220mL)  
Iced coffee (375mL)  
Tea (220mL)  
Hot chocolate drink (220mL)  
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Chocolate milk (330mL)  
Cola soft drink (375mL)  
Cola soft drink (600mL)  
Milk chocolate bar (snack size or approximately 20g)  
Milk chocolate bar (standard size or approximately 50g)  
Milk chocolate bar (king size or approximately 80g)  
White chocolate (snack size or approximately 20g)  
Dark chocolate (snack size or approximately 20g)  
Chocolate biscuit (15g)  
Chocolate cake (75g)  
Energy drink (250mL)  
NoDoz (1 tablet)  
ED Use 
[] 
Have you consumed an energy drink in the past 30 days? * 
Please choose only one of the following: 
 Yes 
 No 
[]How frequently have you consumed an energy drink in the past 30 days? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '38 [q51]' ( Have you consumed an energy drink in the 
past 30 days? ) 
Please choose only one of the following: 
 Monthly or less 
 2 to 4 times per month 
 2 to 3 times per week 
 4 to 6 times per week 
 Daily 
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[]In the past 30 days, how many standard energy drinks did you have on a typical day when 
you were drinking energy drinks? Note: 1 standard ED = 250mL ED containing 
approximately 80mg caffeine (e.g., one serving of Red Bull). * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '38 [q51]' ( Have you consumed an energy drink in the 
past 30 days? ) 
Only numbers may be entered in this field. 
 
Please write your answer here: 
  
[]In the last 30 days, how often did you drink three or more standard energy drinks in one 
day? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '38 [q51]' ( Have you consumed an energy drink in the 
past 30 days? ) 
Please choose only one of the following: 
 Never 
 Monthly or less 
 2 to 4 times per month 
 2 to 3 times per week 
 4 to 6 times per week 
 Every day 
[]In the last 30 days, what is the greatest number of standard energy drinks you have 
consumed in one day? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '38 [q51]' ( Have you consumed an energy drink in the 
past 30 days? ) 
Only numbers may be entered in this field. 
 
Please write your answer here: 
  
Alcohol Use 
[]Have you consumed an alcoholic drink in the last fortnight (i.e., 14 days)? * 
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Please choose only one of the following: 
 Yes 
 No 
[]How many standard alcoholic drinks have you consumed in the last fortnight? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Only numbers may be entered in this field. 
 
Please write your answer here: 
  
[] 
The following questions ask about your alcohol use in the last 12 months. Please note that 
all alcohol quantities are provided in standard drink sizes. All information provided will be 
kept confidential. 
How often do you have a drink containing alcohol? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 Never 
 Monthly or less 
 2 to 4 times a month 
 2 to 3 times a week 
 4 or more times a week 
[]How many standard drinks containing alcohol do you have on a typical day when you are 
drinking? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 1 or 2 
83 
 
 
 
 3 or 4 
 5 or 6 
 7 to 9 
 10 or more 
[]How often do you have six or more standard drinks on one occasion? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 Never 
 Less than monthly 
 Monthly 
 Weekly 
 Daily or almost dialy 
[]How often during the last year have you found that you were not able to stop drinking 
once you had started? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 Never 
 Less than monthly 
 Monthly 
 Weekly 
 Daily or almost daily 
[]How often during the last year have you failed to do what was normally expected of you 
because of drinking? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
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 Never 
 Less than monthly 
 Monthly 
 Weekly 
 Daily or almost daily 
[]How often during the last year have you needed a first drink in the morning to get 
yourself going after a heavy drinking session? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 Never 
 Less than monthly 
 Monthly 
 Weekly 
 Daily or almost daily 
[]How often during the last year have you had a feeling of guilt or remorse after drinking? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 Never 
 Less than monthly 
 Monthly 
 Weekly 
 Daily or almost daily 
[]How often during the last year have you been unable to remember what happened the 
night before because of your drinking? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
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Please choose only one of the following: 
 Never 
 Less than monthly 
 Monthly 
 Weekly 
 Daily or almost daily 
[]Have you or someone else ever been injured because of your drinking? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 No 
 Yes, but not in the last year 
 Yes, in the last year 
[]Has a relative or friend or a doctor or other health worker ever been concerned about 
your drinking or suggested you cut down? * 
Only answer this question if the following conditions are met: 
Answer was 'Yes' at question '43 [q61]' (Have you consumed an alcoholic drink in 
the last fortnight (i.e., 14 days)?) 
Please choose only one of the following: 
 No 
 Yes, but not in the last year 
 Yes, during the last year 
Other Drug Use 
[]How often do you smoke tobacco? * 
Please choose only one of the following: 
 Never 
 Monthly 
 Fortnightly 
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 Weekly 
 Daily or almost daily 
[]Have you used cannabis in the past month? * 
Please choose only one of the following: 
 Yes 
 No 
[]Have you used any form of illicit drugs in the past 6 months? * 
Please choose only one of the following: 
 Yes 
 No 
[]Are you currently regularly taking prescription medication for medicinal or recreational 
purposes? * 
Please choose only one of the following: 
 Yes 
 No 
[]Have you participated in another study within the last three months for which you had to 
consume any drugs? * 
Please choose only one of the following: 
 Yes 
 No 
Statement of Study Restrictions 
[] 
Thank you for answering the previous questions. There are now just a few questions to 
ensure you are aware of what participation involves and to ensure that you will be able to 
complete the study. 
Will you be able to attend one 60 minute familiarisation session and four 270 minute 
experimental sessions at the Hobart campus of the University of Tasmania, beginning at 
either 9am or 1pm? * 
Please choose only one of the following: 
 Yes 
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 No 
[]Are you willing to drink up to six standard alcoholic drinks and three 250mL energy drinks 
per session? Please note that you will not be informed of the specific quantity of 
alcohol/energy drink administered in the beverage until the conclusion of all sessions. * 
Please choose only one of the following: 
 Yes 
 No 
[] 
Prior to each experimental session, participants will be asked to abstain from: 
- Food for 4 hours 
- Caffeine for 8 hours 
- Alcohol for 24 hours 
- Prescription medication for 24 hours 
- Illicit drugs for the duration of participation 
Participants will be provided with a standard breakfast or lunch snack to eat 60 minutes 
prior to each session. Food and drink will also be provided at the end of each session. 
Will you be willing to comply with these restrictions? * 
Please choose only one of the following: 
 Yes 
 No 
[] 
Are you willing to remain in the laboratory until your breath alcohol concentration is 
recorded at .03% or less? 
Provisional licence holders who are intending to drive will have to remain in the laboratory 
until their breath alcohol concentration is .00%.  
If not intending to drive provisional licence holders will have to remain in the laboratory 
until their breath alcohol concentration reaches .03% and be required to organise 
alternative transportation after the session. 
In addition to food and drink, DVDs and magazines will be provided in the interim. * 
Please choose only one of the following: 
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 Yes 
 No 
[]Which session time would you prefer? * 
Please choose all that apply: 
 9am 
 1pm 
[]Please indicate which days would best suit you for completing the experimental sessions. 
Note that the 270 minute sessions will begin at 9am or 1pm and will be separated by a 
minimum of 4 and maximum of 10 days. 
Please choose all that apply: 
 Monday 
 Tuesday 
 Wednesday 
 Thursday 
 Friday 
 Saturday 
 Sunday 
Thank you answering the screening questionnaire, we appreciate your assistance. 
The researchers will be in contact with you as quickly as possible to confirm 
whether you are eligible to participate. Please email Jessica Forward and Jane 
Akhurst at energydrinkstudy@gmail.com if you have any queries or would like a 
copy of the information sheet. 
 
 
 
Submit your survey. 
Thank you for completing this survey. 
 
 
https://surveys.psychol.utas.edu.au 
© University of Tasmania, Australia ABN 30 764 374 782 CRICOS Provider Code 
00586B 
Info line 1300 363 864 
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Appendix C 
Declaration of Abstinence Compliance 
 
 
Participant ID: ..................... 
 
Session Number: 1    2    
 
Declaration of Abstinence Compliance  
 
Participants are required to abstain from the following prior to the experimental 
sessions: 
 
 No nicotine and illicit drugs for the duration of participation 
 No alcohol for 24 hours 
 No prescription medication for 24 hours 
 No caffeine-containing products for 8 hours 
 No food for 4 hours (preceded by a light meal not containing 
oil/dairy/caffeine) 
 
 
 
I solemnly swear that I have complied with the above guidelines prior to this session.  
 
Signature of participant: ...................................................... Date: ................................ 
 
Signature of experimenter: .................................................. Date: ................................ 
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Appendix D 
Participant Information Sheet and Consent Form 
Information Sheet 
 
Alcohol and Energy Drink Component Interactions: Study 1 and Alcohol and 
Energy Drink Component Interactions: Study 2 
March, 2016 
Introduction 
You are invited to participate in an experiment examining the effect of independent 
and combined consumption of energy drinks and alcohol on performance. The 
purpose of this study is to investigate whether energy drinks alter the impact of 
alcohol on risk-taking through measurement of behavioural outcomes. The research 
is being conducted by Holly Bromfield and Xiao Min Leong in partial fulfilment of 
the requirements of an Honours degree. Holly and Xiao are being supervised by Dr 
Raimondo Bruno and Dr Amy Peacock from the School of Psychology, University 
of Tasmania. The researchers can be contacted as following:  Holly Bromfield; 
hollyb1@utas.edu.au: + 61 3 6226 2924; Xiao Min Leong; xmleong@utas.edu.au; + 
61 3 6226 2924).  
 
What is the purpose of the study? 
The purpose of this study is to investigate whether energy drinks or 
caffeinated/sugary drinks alter the impact of alcohol on performance through 
measurement of behavioural (e.g., reaction time, accuracy, decision-making ) 
outcomes; and to compare subjective and objective measures of intoxication. 
 
Who can participate? 
We are currently seeking participants who are: 
 Male/Female 
 Aged 18-35 years 
 English as a first language 
 Completed Year 12 
 Normal or corrected-to-normal vision 
 Normal sleep patterns 
 Healthy (no history of significant neurological disorder or current psychiatric 
disorder, significant intellectual disorder, alcohol/drug dependence, regular 
tobacco use, or chronic health problems) 
 Regular energy drink consumers (minimum consumption of 1 energy drink in 
the preceding month and maximum consumption of 1 energy drink per day in 
the last month) 
 Regular caffeine consumers (minimum consumption of 5 caffeinated 
beverages in the last week) 
 Regular alcohol consumers (minimum consumption of 5 standard alcoholic 
drinks on one occasion in the preceding month) 
 Not currently using illicit drugs (i.e., use in the preceding six months) 
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 Able to attend the Hobart campus of the University of Tasmania for one 60-
minute session commencing at a time between 9am and 5pm, and two240 
minute sessions commencing at 9am or 1pm. 
 
What does participation in the study involve? 
This research will be conducted in the Perception Laboratory at the School of 
Psychology, University of Tasmania (Hobart). Interested individuals will complete a 
brief screening questionnaire online that collects data about demographics (e.g., age, 
sex), medical history, and use of caffeine, alcohol, energy drinks and other drugs. 
Eligible participants will be asked to attend the Perception Laboratory for three 
sessions: one familiarisation session conducted between 9am and 5pm and two 
experimental sessions commencing at either 9am or 1pm and separated by a 
minimum of 4 and maximum of 14 days. 
 
Familiarisation session (session 1: 60-minutes duration) 
To confirm eligibility prior to participation, volunteers will be asked to complete 
several paper screening questionnaires in person, including measures of general 
intellectual and psychological functioning. 
If participants are deemed eligible following completion of these measures, they will 
be asked to complete a number of other measures assessing personality, and alcohol, 
caffeine, and energy drink use, and their height and weight will be measured. 
Participants will then practice the tasks which will be completed in the experimental 
sessions. 
 
Experimental sessions (session 2 x 240 minutes duration/session) 
At the beginning of each experimental session participants will consume a different 
beverage containing energy drink and/or alcohol and/or sugar and/or caffeine. 
Alcohol and energy drink content will be equivalent to a maximum of 6 standard 
alcoholic drinks, 3 250mL energy drinks, respectively per session. The caffeine 
beverage will contain the equivalent caffeine as the energy drink, the sugar beverage 
will contain equivalent sugar of the energy drink. Participants will not be informed 
of the beverage content administered in each session until the conclusion of all 
sessions.  
 
After consuming the beverage, participants will be asked to complete a range of 
computerised behavioural laboratory tasks while their responses are recorded. A 
breathalyser will be used to monitor participants’ breath alcohol concentration 
throughout the duration of the study. Throughout testing, participants will be asked 
to complete several scales assessing their mood and feeling of intoxication and 
impairment as well as computerised tasks. Participants will be debriefed regarding 
the order of dose administration at the conclusion of all sessions.  
 
What are the restrictions regarding participating? 
Participants will be asked to fast from food for 4 hours prior to each experimental 
session and abstain from caffeine for 8 hours and alcohol and prescription 
medication for 24 hours prior to each session. Participants will be asked to abstain 
from illicit drugs and tobacco for the duration of participation. Participants will be 
asked to consume a standard meal (provided in the familiarisation session) one hour 
prior to each session. 
 
92 
 
 
 
At the end of each session, participants will remain at leisure (with food and 
entertainment provided) until they attain two consecutive breathalyser recordings of 
0.03% or less measured 15 minutes apart.  
 
Participants holding their provisional driver licence, who are intending to drive will 
be required to remain in the laboratory until two consecutive BrAC measurements 
are recorded at .00%.  Participants holding their provisional licence who are not 
intending to drive, will be able to leave the laboratory at .03% BrAC if they sign a 
declaration in which they agree to be escorted by a nominated guardian to their place 
of residence and accompanied for a two-hour period following session completion.  
The nominated guardian must be an adult aged 18 years or older who: (i) holds their 
provisional or full driver licence (ii) directly collects the participant from the 
research premises and meets the researcher in-person, and (iii) signs a declaration 
agreeing to escort the participant directly to their place of residence and accompany 
the participant for the two-hour period following session completion.  The researcher 
reserves the right to retain participants in the laboratory until .03% BrAC for those 
holding their full driver licence and .00% BrAC for those holding their provisional 
licence when it is deemed unsafe for the participant to leave at .03% BrAC. 
 
What are the benefits of participating?  
Your participation will help us enhance our knowledge of the effects of popular 
energy drinks on people’s perceived and actual level of alcohol-induced impairment. 
This knowledge can be used to help educate people regarding the potential outcomes 
of independent and combined alcohol and energy drink or caffeinated drink use.  
 
What are the risks associated with participating? 
There are no anticipated risks of this research. However, if in the unlikely event you 
experience negative side-effects, please inform the experimenter and the necessary 
assistance will be sought and provided. We ask that participants refrain from 
consuming alcohol or operating heavy machinery for four hours’ post-session.  
 
Is there any monetary reimbursement for participation? 
Participants will be reimbursed $80 (i.e. $40 per experimental session) at the 
conclusion of the sessions as recompense for their time. Participants who do not 
complete the full schedule of sessions will not be reimbursed, unless withdrawal is 
necessary due to an unexpected adverse physiological reaction to the investigatory 
products. Partial reimbursement will be provided in this situation dependent on the 
number of sessions completed. KHA111/112 students may receive up to 8-hours 
research participation credit as reimbursement for time and expenses incurred, with a 
deduction of $10 monetary reimbursement for each hour of research participation 
credit awarded (e.g. total reimbursement of 6 hours credit plus $20, 5 hours credit 
plus $10, etc.). 
 
How do I volunteer to participate? What if I want to withdraw from 
participating? 
Participation in this study is voluntary. By signing the attached consent form, you are 
indicating that you are aware of the nature of the study and wish to participate. While 
we would be pleased to have you participate, we respect your right to decline. There 
will be no consequences to you if you decide not to participate. If you decide to 
discontinue participation at any time, you may do so without providing an 
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explanation. However, you will be required to remain in the laboratory until your 
breath alcohol concentration measurement equals 0.03% or less on two separate 
occasions measured 15 minutes apart. 
 
What will happen to the information I provide? 
All information collected will be kept confidential. Each participant will be assigned 
a treatment code and individual participant data will be identifiable only by that 
code. All of the data will be stored on password protected secure computers or in a 
locked cabinet in the School of Psychology for a minimum of five years after the 
publication of any academic journal articles, at which point all questionnaires will be 
destroyed using a paper shredder and electronic data will be deleted. The screening 
questionnaire will be securely destroyed immediately on completion of the study and 
that any information provided by the participant on the questionnaire will be 
identifiable only by participant number, kept confidential, and viewed only by the 
experimenter. 
 
Who do I contact if I have any queries? 
If you would like to discuss any aspect of this study, please contact Holly Bromfield 
(hollyb1@utas.edu.au; + 61 3 6226 2924) or Xiao Min Leong 
(xmleong@utas.edu.au; +61 3 6226 2924). Alternatively, you can contact Dr 
Raimondo Bruno on (03) 6226 2240 or email Raimondo.Bruno@utas.edu.au.  
 
How do I find out the results of the study? 
A summary of the results will be available on the Research webpage of the School of 
Psychology, University of Tasmania (http://fcms.its.utas.edu.au/scieng/psychol/). 
Results of the study can also be provided by Holly Bromfield (hollyb1@utas.edu.au; 
+ 61 3 6226 2924) or Xiao Min Leong (xmleong@utas.edu.au; +61 3 6226 2924)  
 
Who do I contact if I have a complaint about the study? 
This study has been approved by the Tasmanian Social Science Human Research 
Ethics Committee.  If you have concerns or complaints about the conduct of this 
study should contact the Executive Officer of the HREC (Tasmania) Network on 
(03) 6226 7479 or email human.ethics@utas.edu.au.  The Executive Officer is the 
person nominated to receive complaints from research participants. You will need to 
quote. 
 
Thank you for taking the time to consider this study. 
If you wish to take part in it, please sign the attached consent form. 
This information sheet is for you to keep.
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School of Psychology 
University of Tasmania 
 
Consent Form 
 
Alcohol and Energy Drink Component Interactions: Study 1 and Alcohol and 
Energy Drink Component Interactions: Study 2 
1. I have read and understood the 'Information Sheet' for this project. 
2. The nature and possible effects of the study have been explained to me. 
3.  I understand that the study involves attending the Cognitive Neuroscience 
Laboratory for one 60 minute familiarisation session and two 240 minute 
experimental sessions. 
4.  I understand that in the familiarisation session I will complete measures of 
psychological distress, premorbid intelligence, and alcohol use, as well as having my 
height and weight measured. If I am eligible to participate in the study, I will be 
asked to complete further measures of personality, behaviour and alcohol, caffeine, 
and energy drink use. I will also practice the tasks which form part of the 
experimental sessions. 
5. I understand that I will be asked to abstain from food for 4 hours, caffeine-
containing products for 8 hours, and alcohol and prescription medication for 24 
hours prior to each session, and illicit drugs and tobacco for the duration of the 
study. I will be asked to consume a provided standard meal 60 minutes prior to each 
experimental session. I will be asked to sign a declaration and complete a breath 
alcohol concentration measurement (via a breathalyser) to confirm my abstinence at 
the start of each session. 
6. I understand that in the two sessions I will receive a beverage containing 
energy drinks and/or alcohol and/or caffeine and/or sugar. I understand that I may be 
given a maximum of 6 standard alcoholic drinks and 3 250mL energy drinks per 
session, and that I will not be informed of the specific contents of the beverage for 
each session until the conclusion of testing. I understand that after beverage 
consumption, I will be asked to complete a number of computerised laboratory 
behavioural performance tasks during which my behavioural responses will be 
recorded. I understand that my breath alcohol concentration (as measured via a 
breathalyser) will be recorded throughout the session, and that I will be asked about 
my perception of my intoxication and level of impairment and will be required to 
complete computerised tasks. 
7.  I understand that I will be asked to remain in the laboratory until my blood 
alcohol concentration equals 0.03% or less on two occasions measured 15 minutes 
apart. I acknowledge that I have been advised to refrain from drinking alcohol or 
operating a vehicle or other heavy machinery for four hours after the end of the 
experimental session. 
8.  I understand that if I hold a provisional driver licence and I intend to drive I 
will be required to remain in the laboratory until my breath alcohol concentration is 
.00% on two consecutive occasions.  I understand that if I hold a provisional driver 
licence and do not intend to drive I will be able to leave the laboratory at .030% 
BrAC after signing a declaration in which I agree to be escorted by my nominated 
legal adult to my place of residence and be accompanied for a two-hour period 
following session completion.  I understand that the nominated legal guardian must 
be an adult aged 21 years or older who: (i) holds their provisional or full driver 
licence (ii) directly collects me from the research premises and meets the researcher 
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in-person, and (iii) signs a declaration agreeing to escort me directly to my place of 
residence and accompany me for the two-hour period following session completion.  
Furthermore, I understand that the researcher reserves the right to retain participants 
in the laboratory until .03% BrAC for those holding their full driver licence and 
.00% BrAC for those holding their provisional licence when it is deemed unsafe for 
the participant to leave at .03% BrAC.  I acknowledge that I have been advised to 
refrain from drinking alcohol or operating a vehicle or other heavy machinery for 
four hours after the end of experimental sessions. 
9.  I understand that I will be reimbursed $80 (i.e., $40 per experimental session) 
for my participation on conclusion of the two experimental sessions. I understand 
that if I am a KHA111/112 student I can opt to be reimbursed up to six hours 
research participation credit in addition to at least $20 monetary reimbursement. If I 
withdraw from the study prior to concluding all sessions I will not be eligible for 
monetary reimbursement, unless the withdrawal is due to an unexpected adverse 
event occurring as a consequence of ingesting the beverage, whereby I will be 
provided partial reimbursement consummate with the number of sessions completed. 
10. I understand that, while there are no anticipated risks associated with this 
study, I should inform the experimenter immediately if any unexpected negative 
side-effects are experienced. I understand the experimenter will immediately cease 
the session and seek the necessary assistance. 
11.  I understand that the researchers will maintain my confidentiality and that 
any information I supply to the researcher(s) will be used only for the purposes of 
the research. My data will only be identifiable by an individual numerical participant 
code. 
12.  I understand that the screening questionnaire will be securely destroyed 
immediately on completion of the study and that any information I provide on the 
questionnaire will be identifiable only by my participant number, kept confidential, 
and viewed only by the experimenter.  
13. I understand that all research data will be securely stored on the University of 
Tasmania premises for at least five years, and will then be securely destroyed when 
no longer required.  
14. I agree that research data gathered from me for the study may be published 
provided that I cannot be identified as a participant. 
15. I agree to participate in this investigation and understand that I may withdraw 
at any time without any effect, and if I so wish, may request that any data I have 
supplied to date be withdrawn from the research. 
16. Any questions that I have asked have been answered to my satisfaction. 
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Name of Participant: 
Signature: Date: 
 
Statement by Investigator  
 I have explained the project & the implications of participation in it to 
this volunteer and I believe that the consent is informed and that 
he/she understands the implications of participation  
If the Investigator has not had an opportunity to talk to participants prior to 
them participating, the following must be ticked. 
 The participant has received the Information Sheet where my details 
have been provided so participants have the opportunity to contact me 
prior to consenting to participate in this project. 
 
Name of investigator   
  
Signature of investigator                           
 
Date 
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Appendix E 
Table 11 
Pairwise comparisons of Time x Sex Interaction on BrAC recorded prior to A-BART administration and BrAC recorded prior to DT 
administration, with Significance Values (p<0.05) and Effect Sizes (Hedge’s g) 
  Baseline  (35-mins)  (75-mins)  (115-mins)  (155-mins)  (205-mins) 
 
 
 
 
 
Female 
vs. Male 
 Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
BrAC  
A-BART 
.884 <.001 .004 0.93 <.001 1.77 <.001 2.43 <.001 1.26 <.001 2.34 
BrAC DT .814 0.09 .005 0.93 < .001 1.49 < .001 2.24 < .001 2.62 < .001 2.24 
NB: Hedge’s gs>0.40 appear in bold. Ps <.050 appear in italics 
9
7
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Table 12 
Pairwise comparisons for Time x Sex interactions on DT RT (females), with Significance Values (p<0.05) and Effect Sizes (Hedge’s g) 
 Baseline Time 1 
(25-mins) 
Time 2 
(65-mins) 
Time 3 
(105-mins) 
Time 4 
(145-mins) 
Time 5 
(195-mins) 
 Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Time 0   .055 0.19 .055 0.33 .028 0.30 .099 0.25 .195 0.19 
Time 1 .055 0.19   .033 0.16 .508 0.29 .508 0.07 .961 0.01 
Time 2 .005 0.33 .033 0.16   .362 0.03 .362 0.07 .156 0.14 
Time 3 .028 0.30 .161 0.13 .735 0.03   .489 0.20 .239 0.08 
Time 4 .099 0.25 .508 0.07 .362 0.07 .489 0.05   .545 0.06 
Time 5 .195 0.19 .961 0.01 .156 0.14 .239 0.14 .545 0.06   
NB: Hedge’s gs>0.40 appear in bold. Ps < .050 appear in italics 
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Table 13 
Pairwise comparisons for Time x Sex interactions on DT RT (males), with Significance Values (p <0.05) and Effect Sizes (Hedge’s g) 
 Baseline Time 1 
(24-mins) 
Time 2 
(65-mins) 
Time 3 
(105-mins) 
Time 4 
(145-mins) 
Time 5 
(195-mins) 
 Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Sig. 
value 
Effect 
size 
Time 0   <.001 0.48 <.001 0.46 <.001 0.30 <.001 0.75 <.001 0.61 
Time 1 <001 0.48   .290 0.07 .037 0.16 <.001 0.36 .013 0.23 
Time 2 <.001 0.46 .290 0.07   .255 0.09 .001 0.28 .081 0.16 
Time 3 <.001 0.30 .037 0.16 .255 0.09   .017 0.05 .401 0.14 
Time 4 <.001 0.75 <.001 0.36 .001 0.28 .017 0.20   .269 0.12 
Time 5 <.001 .611 .013 .232 .081 0.16 .401 0.08 .269 .116   
NB: Hedge’s gs>0.40 appear in bold. Ps < .050 appear in italics 
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Appendix F 
For SPSS out-put please see CD inside cover. 
 
